Section 36

EurekaMag Full Text Articles Chapter 35,454


Tozaki, T. 2002: PCR procedure for the isolation of trinucleotide repeats. Methods in Molecular Biology 192: 81-89
Irwin, D.L.; Mitchelson, K.R.; Findlay, I. 2003: PCR product cleanup methods for capillary electrophoresis. Biotechniques 34(5): 932
Smith, E.S.; Wang, A.M.; Gelfand, D.H. 1999: PCR product cloning with primers containing inverted nucleotides. Abstracts of the General Meeting of the American Society for Microbiology 99: 333
Carramao, J.; Wu, H.C.; Azarani, A. 2003: PCR purification with a 96-well PCR cleanup kit on high-throughput liquid handling systems. American Biotechnology Laboratory 21(1): 16, 18
Brewood, G.P.; Rangel, D.; Nguyen, E.; Aliwarga, T.; Schurr, J.M.chael 2004: PCR puzzles. Biophysical Journal 86(1): 312a-313a
Zhong, X.; Holzgreve, W.; Hahn, S. 2003: PCR quantitation of fetal cells in maternal blood is significantly compromised by presence of cell free fetal DNA. American Journal of Human Genetics 73(5): 594
Thum, T.; Borlak, J. 2003: PCR reaction mixture for fluorescence-based gene expression and gene mutation analyses. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)
Araujo, F.M.G.; Cruz, R.E.; Magalhaes, N.M.; Lopes, A.M.; Bahia, M.T.; Veloso, V.M.; Martins Filho, O.A.; Galvao, L.M.C.; Tafuri, W.L.; Lana, M. 1999: PCR reaction, parasitological and serological data during the chronic phase of experimental Chagas disease in dogs. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 184
Bordenkircher, G.L.; Lim, G.; Freudenthal, J.K.ppel 2003: PCR sample handling device. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)
Lehoux, D.E.; Levesque, R.C. 2002: PCR screening in signature-tagged mutagenesis of essential genes. Methods in Molecular Biology 192: 225-234
Matoska, V.; Boday, A.; Zumrova, A.; Kraus, J.; Seemanova, E. 1999: PCR screening of Friedreichs ataxia in population of spinocerebellar ataxia in Czech Republic. European Journal of Human Genetics 7(Suppl 1): 144
Weber, M.; Roth, W.K.; Drosten, C.; Wichmann, M. 2000: PCR screening of anti-HBc positive blood donations. Vox Sanguinis 78(Suppl 1): P450
Wienbeck, M.; Pfadenhauer, K.; Wagner, T.; Haas, C.J. 2002: PCR should become standard in searching for Whipples disease. Gastroenterology 122(4 Suppl 1): A-192
Mclachrinou, M.; Contis, L.; Locker, J. 1999: PCR strategy for the detection of clonality in B-lineage neoplasms and comparison with Southern blot. Modern Pathology 12(1): 143A
Miller, R.L.; Zhu, B.; Smith, M.; Nelson, R.D. 2002: PCR subtraction cloning of principal cell specific cDNAs using FACS isolated cells from AQP2-EGFP transgenic mice. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 270A
Roberts, S.; Chang, J.; Heard, K.; Steinberg, K.; Gallagher, M. 2002: PCR system to reduce allele drop out and preferential amplification in genotyping low concentration/low quality DNA samples. American Journal of Human Genetics 71(4 Suppl): 401
Bastaki, L.A.; Alwadi, S.A.; Hegazi, F.A.; Turky, N.A.; Mustafa, M.A.; Naguib, K.A. 2002: PCR technique and significance in fragile X syndrome. American Journal of Human Genetics 71(4 Suppl): 523
Arup, U. 2002: PCR techniques and automated sequencing in lichens. Kranner, Ilse, Beckett, Richard, Varma, Ajit Springer Lab Manuals Protocols in lichenology: Culturing, biochemistry, ecophysiology and use in biomonitoring 392-411
Romick, T.L.; Fraser, M.S. 2002: PCR techniques for detecting microbial contaminants in foodstuffs. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)
Kashkin, K.N.; Perevoschikov, A.G.; Nikolaev, A.V.; Turbin, D.A.; Fleischman, E.W. 2000: PCR test for deletions of two genetic loci may be used for post-resectional prognosis in colorectal cancer. Pathology International 50(Suppl): A100
Flanagan, P.; Barbara, J. 1999: PCR testing of plasma pools: from concept to reality. Transfusion Medicine Reviews 13(3): 164-176
Gabriel, D.W. 2001: PCR tests based on required, host-specific, pathogenicity genes. Phytopathology 91(6 Suppl): S152
Benett, W.J.; Richards, J.B. 2003: PCR thermocycler. Official Gazette of the United States Patent and Trademark Office Patents 1266(1)
Hamrah, P.; Mietz, H.; Wieland, U.; Pfister, H.; Heimann, K. 1999: PCR to detect histoplasma capsulatum in SRNVM specimens. IOVS Investigative Ophthalmology and Visual Science 40(4): S988
Alarcón, T.; Domingo, D.; Prieto, N.; López-Brea, M. 2000: PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. Journal of Clinical Microbiology 38(2): 923-925
Calhau, V.; Tacão, M.; Morgado, F.; Correia, A.; Henriques, I. 2010: PCR-DGGE-based methodologies to assess diversity and dynamics of Aeromonas communities. Journal of Applied Microbiology 108(2): 611-623
Ladetto, M.; Drandi, D.; Volpato, F.; Astolfi, M.; Voena, C.; Novarino, A.; Pollio, B.; Addeo, A.; Vallet, S.; Corradini, P.; Bertetto, O.; Boccadoro, M. 2002: PCR-Detectable Non-Neoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis, but Rare after Chemotherapy. Blood 100(11): Abstract No. 1192
Cervantes, A.; Lopez, M.; Yanez, R.G.; Monroy, N.; Aguinaga, M.; Valdez, H.; Sierra, C.; Canun, S.; Guizar, J.; Navarrete, C.; Zafra, G.; Salamanca, F.; Kofman, S. 1999: PCR-FISH-PRINS analysis of marker chromosomes in 8 patients with Turner phenotype. American Journal of Human Genetics 65(4): A159
Motin, V.L.; Georgescu, A.; Elliott, J.; Hu, P.; Worsham, P.L.; Friedlander, A.M.; Brubaker, R.R.; Garcia, E. 2000: PCR-IS100-based fingerprinting of a large collection of Yersinia pestis strains unraveled a putative ancestor isolate to the one that caused the third plague pandemic. Abstracts of the General Meeting of the American Society for Microbiology 100: 263
Usami, T.; Yamakawa, Y. 1999: PCR-RAPD of vines grown from self-pollinated Koshu seedlings. American Journal of Enology and Viticulture 50(2): 226
Yoshida, K.; Teah, Q.S.; Yamakawa, Y. 2001: PCR-RAPD patterns of self-pollinated Koshu grapevines. American Journal of Enology and Viticulture 52(3): 284
Caeiro, B.; Ordonez, A.F.; Luis, J.R.; Carril, J.C. 2000: PCR-RFLP Y-polymorphisms and their application to a Northern African population. Sensabaugh, George F Author, Lincoln, Patrick Journal Author, Olaisen, Bjornar Author International Congress Series Progress in forensic genetics 8 287-289
Lo Presti, R.; Gasco, L.; Lisa, C.; Zoccarato, I.; Di Stasio, L. 2010: PCR-RFLP analysis of mitochondrial DNA in tench Tinca tinca. Journal of Fish Biology 76(2): 401-407
Kobayashi, E.; Shimanuki, S.; Akita, T.; Minezawa, M.; Awata, T. 2001: PCR-RFLP analysis of the estrogen receptor gene in four pig breeds. Japanese Journal of Swine Science 38(3): 125-129
Dieterle, C.; Conzelmann, M.; Linnemann, U.; Berger, M.R. 2002: PCR-RFLP detection of K-ras codon 12 and 13 mutations in tumor, mucosa, lymph node, liver and bone marrow of 200 colorectal cancer patients. Proceedings of the American Association for Cancer Research 43: 216
Sayhan, N.; Bayram Gurel, C.; Yilmaz, A.; Ulutin, T.; Ulutin, O.N. 2000: PCR-RFLP detection of PAI-2 gene variants and ACE gene polymorphism in myocardial infarction. Haemostasis 30(Suppl 1): 140
Imwong, M.; Looareesuwan, S.; Pukrittayakamee, S.; Pasvol, G.; Poirriez, J.; White, N.J.; Snounou, G. 1999: PCR-RFLP detection of Plasmodium vivax DHFR mutations and their geographic distribution. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 337
Gomez Moliner, B.J.; Cabria, M.T.; Rubines, J.; Garin, I.; Madeira, M.J.; Elejalde, A.; Aihartza, J.; Fournier, P.; Palazon, S. 2004: PCR-RFLP identification of mustelid species European mink , American mink and polecat by analysis of excremental DNA. Journal of Zoology (London) 262(Part 3): 311-316
Kim, S.H.; Schroeder, S.; Breuil, C. 2001: PCR-RFLP marker differentiation of Ophiostoma piliferum from other Ophiostoma sapstaining species. Phytopathology 91(6 Suppl): S185
Carrera, E.; Garcia, T.; Cespedes, A.; Gonzalez, I.; Fernandez, A.; Hernandez, P.E.; Martin, R. 1999: PCR-RFLP of the mitochondrial cytochrome oxidase gene A simple method for discrimination between Atlantic salmon and rainbow trout. Journal of the Science of Food and Agriculture 79(12): 1654-1658
Iwahori, H.; Sano, Z.; Ogawa, T. 2000: PCR-RFLP-based survey of plant parasitic nematodes associated with sweet potato and taro in Kyushu, Japan. Journal of Nematology 32(4): 435-436
Gaitanis, G.; Velegraki, A.; Menounos, P.; Frangoulis, E.; Legakis, N.J.; Katsambas, A. 2002: PCR-SSCP analysis A powerful tool for Malassezia species population genetics in related inflammatory dermatoses. Journal of Investigative Dermatology 119(1): 269
Shinahara, K.; Saijo, T.; Mori, K.; Kuroda, Y. 1999: PCR-SSCP analysis of FMR1 gene in autistic and mentally retarded children in Japan. American Journal of Human Genetics 65(4): A344
Matthias, M.A.; Levett, P.N. 1999: PCR-SSCP analysis of Leptospira interrogans sensu lato serovars isolated in Barbados. Abstracts of the General Meeting of the American Society for Microbiology 99: 187
Chung, E.R.; Kim, W.T.; Kim, Y.S.; Hwang, S.W.; Lee, C.S. 2000: PCR-SSCP genotype effects of growth hormone, prolactin and insulin-like growth factor-1 genes on milk yield in Korean Cattle. Asian-Australasian Journal of Animal Sciences 13(Suppl Vol A): 223
Blair, A.; Bugawan, T.L.; Erlich, H.A. 2002: PCR-SSOP Reverse Line Blot assay for Type I Diabetes genetic risk HLA and non-HLA markers. Human Immunology 63(Suppl 1): S59
Williams, F.; Meenagh, A.; Ross, O.; Gorodezky, C.; Hammond, M.; Middleton, D. 2002: PCR-SSOP identification of cytokine polymorphisms in five geographically diverse populations. European Journal of Immunogenetics 29(2): 138
Mascaretti, L.; Luciano, A.; Marziliano, N.; Riva, M.; Trezzi, D.; Sciorelli, G. 2000: PCR-SSP HLA-DQ fluorotyping using SYBR green. Human Immunology 61(Suppl 1): S104
Meyer, M.; Opelz, G.; Mytilineos, J. 2004: PCR-SSP analysis of single nucleotide polymorphisms in costimulatory molecule genes as well as in genes involved in the blood clotting cascade Genotype frequencies in 198 healthy, German caucasian donors. Genes and Immunity 5(Suppl 1): S12
Arora, B.A.; Wiley, K.R.; Shi, Y.F.; Kumar, P. 2001: PCR-SSP typing for HLA class I antigens in the cadaveric donor specimen Improvements to the current protocol. Human Immunology 62(Suppl 1): S150
Grimsley, C.; Gassner, C.; Geraghty, D.E. 2000: PCR-SSP typing for HLA-E. Human Immunology 61(Suppl 1): S103
Mytilineos, J.; Preiss, A.; Opelz, G. 1999: PCR-SSP typing for IL10, TNFA and TGFbeta promotor gene poly-morphisms in Caucasian and African American individuals. Human Immunology 60(Suppl 2): S29
Mytilineos, J.; Preiss, A.; Hawkins, B.; Opelz, G. 2000: PCR-SSP typing for IL10, TNFalpha and TGFbeta promoter gene polymorphisms in Caucasian and Hong Kong Chinese individuals. Human Immunology 61(Suppl 1): S137
Medis, R.; Marlowe, M.; Partel, R.; Tomines, E.; Wetzsteon, P.; Curtin, P.; Maziarz, R.; Norman, D.; Endres, R.O. 2003: PCR-SSP typing of an apparently homozygous A31 individual reveals the serologically undetected HLA-A*2411N allele. Human Immunology 64(Suppl 1): S56
Dastoor, F.P.; Annis, S.L.; Daszak, P.; Longcore, J.E.; Jones, M.S.; Muths, E. 2001: PCR-assay to detect Batrachochytrium on amphibians and in the environment. Phytopathology 91(6 Suppl): S108
Noreen, H.J.; Maiers, M.; Setterholm, M.; Shipp, K.; Hurley, C. 1999: PCR-based HLA-A, B typing of 42,160 serologically typed individuals in the NMDP registry. Human Immunology 60(Suppl 2): S133
Lee, S.W.; Kwon, O.S.; Kwon, S.I.; Jeen, Y.T.; Chun, H.J.; Lee, H.S.; Song, C.W.; Um, S.H.; Choi, J.H.; Kim, C.D.; Ryu, H.S.; Hyun, J.H. 1999: PCR-based RFLP patterns in Korean duodenal ulcer patients before and after anti-helicobacter pylori triple therapy. Gut 45(Suppl 3): A114
Larsen, R.C.; Vandemark, G.J.; Gritsenko, M.A.; Hollingsworth, C.R.; Gray, F.A. 2001: PCR-based SCAR markers for the detection and identification of Phoma sclerotiodes The cause of brown root rot disease of alfalfa. Phytopathology 91(6 Suppl): S53
Nadji, A.R.; Kashani, S.; Jalil Nejad, S.; Karimi Nejad, A.; Najmabadi, H. 2001: PCR-based analysis of infectious teratogen in amnion fluid. European Journal of Human Genetics 9(Suppl 1): P0696
Frebourg, N.B.; Lefebvre, S.; Baert, S.; Lemeland, J.F. 2000: PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. Journal of Clinical Microbiology 38(2): 877-880
D'alessandro, L.P.; Virgili, S.G.; Rossetti, S.B. 1999: PCR-based assay of aqueous humor samples for the diagnosis of infectious uveitis. IOVS Investigative Ophthalmology and Visual Science 40(4): S863
Christopherson, C.; Kidane, Y.; Conway, B.; Krowka, J.; Sheppard, H.; Kwok, S. 2000: PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. Journal of Clinical Microbiology 38(2): 630-634
Owen, R.J.; Sharp, S.I.; Rijpkema, S.; Chisholm, S.A. 2001: PCR-based assays for identification of Helicobacter pylori cagA tyrosine phosphorylation motifs and frequencies in isolates from peptic ulcers and other gastric diseases. IJMM International Journal of Medical Microbiology 291(Suppl 31): 30
Shishido,M.; Sato,K.; Yoshida,N.; Tsukui,R.; Usami,T. 2010: PCR-based assays to detect and quantify Phomopsis sclerotioides in plants and soil. Journal Of General Plant Pathology: 1, 21-30
Slateva, K.; Blasczyk, R. 1999: PCR-based characterization of DNA isolates as a reference for the definition of homozygosity by fluorotyping. Human Immunology 60(Suppl 1): S45
Beck, J.J.; Barnett, C.J. 2001: PCR-based detection and quantification of Tapesia yallundae and Tapesia acuformis. Official Gazette of the United States Patent and Trademark Office Patents 1252(3)
Matar, G.M.; Sidani, N.; Fayad, M.; Hadi, U. 1999: PCR-based detection and subtyping of bacterial etiology of otitis media with effusion in infected Lebanese children. Abstracts of the General Meeting of the American Society for Microbiology 99: 204
Chisholm, S.A.; Owen, R.J.; Teare, E.L.; Anjum, F.H.; Lewi, H. 2000: PCR-based detection of Helicobacter spp in bladder biopsies A novel risk factor for patients with chronic interstitial cystitis?. Gut 47(Suppl 1): A90
Allaire, M.; Bernier, L.; Vujanovic, V.; St Arnaud, M.; Filion, M.; Hamelin, R.C. 2003: PCR-based detection of Pseudomonas spp capable of producing antibiotics in the rhizosphere of conifers. Phytopathology 93(6 Suppl): S132
Goldmann, T.; Richter, E.; Galle, J.; Deutschbein, M.E.; Vollmer, E. 2000: PCR-based detection of mycobacteria in paraffin embedded specimens A molecular biological technique expanding the facilities of conventional stainings. Pathology Research and Practice 196(6): 350
Teixeira, M.G.M.; Oelemann, W.M.R.; Caseca, A.; Borges Pereira, J.; Peralta, J.M. 1999: PCR-based diagnosis for Chagas disease in treated or non-treated patients living in endemic area. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 146
Van Der Zee, A.; Peeters, M.; Buiting, A.; Bergmans, A. 1999: PCR-based diagnosis of Legionella pneumophila infections. Journal of Microbiological Methods 38(3): 197
Filippova, Y.; Oksema, E.; Konovalenko, I.; Kusmina, V.; Lyshchov, A.; Rudenko, V. 2001: PCR-based diagnosis of bacteriemia. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S231
Steenkamp, E.T.; Wingfield, B.D.; Coutinho, T.A.; Wingfield, M.J.; Marasas, W.F.O.; Leslie, J.F. 1999: PCR-based differentiation of MAT-1 and MAT-2 from Gibberella fujikuroi mating population H. Phytopathology 89(6 Suppl): S75
Maroon, C.J.M.; Zavriev, S. 2000: PCR-based group tests for the detection of tobamo-, carla-, nepo- and potexviruses in plant samples. Phytopathology 90(6 Suppl): S49
Gasser, R.B.; Woods, W.G.; Richards, D.G.; Whithear, K.G. 2002: PCR-based identification of Eimeria species and strains. Official Gazette of the United States Patent and Trademark Office Patents 1261(2)
Potter, E.T.; Leroy, A.; Woo, H.; Hirsch, A.M.; Heber, D. 2002: PCR-based identification of degraded DNA and monitoring of flavonoids isolated from alfalfa and red clover commercial preparations used as botanicals in dietary supplements. Plant Biology (Rockville) : 38
Tsuzuki, K.; Tricoire, L.; Nathalie, G.; Rossier, J.; Ozawa, S.; Lambolez, B. 2003: PCR-based in vitro mutagenesis of the photoprotein aequorin. Neuroscience Research Suppl (26): S136
Davies, N.; Guggenheim, J.A.; Wigham, C.G. 2001: PCR-based investigations of chloride channels in rabbit corneal endothelium. IOVS Investigative Ophthalmology and Visual Science 42(4): S275
Larsen, R.C.; Vandemark, G.J.; Gray, F.A.; Gritsenko, M. 2001: PCR-based markers for the identification of Phoma sclerotiodes infecting alfalfa. Phytopathology 91(6 Suppl): S186
Burdychova, R.; Ruzicka, V.; Bartos, M. 2002: PCR-based method for identification of integration events in the Pichia pastoris genome. Biotechniques 33(6): 1214-6 1218
Dean, R.A.; Wang, Y.H.ng 2001: PCR-based method for identifying a fusarium wilt-resistant genotype in plants. Official Gazette of the United States Patent and Trademark Office Patents 1251(5)
Queirós, O.; Casal, M.; Moradas-Ferreira, P.; Leão, C. 2001: PCR-based method for the construction of gene disruption cassettes in yeast. Biotechniques 31(2): 264-266; 268
Szostakowska, B.; Myjak, P. 2000: PCR-based methods for identification of Baltic anisakids. Acta Parasitologica 45(3): 262
Velinov, M.; Gu, H.; Genovese, M.; Duncan, C.; Brown, W.T.; Jenkins, E. 1999: PCR-based methylation testing of archived fixed cell suspensions from individuals previously tested by cytogenetics/FISH for Prader-Willi or Angelman syndromes. American Journal of Human Genetics 65(4): A410
Oprisan, G.; Guillot, S.; Caro, V.; Popa, L.; Combiescu, M.; Persu, A. 2003: PCR-based molecular systems developed in the enterovirus 3D polymerase coding region Applications for differentiation between enteroviruses and detection of natural heterotypic recombinants. FEMS Congress of European Microbiologists Abstract Book 1: 483
Chakrabarti, S.; Collingham, K.; Pillay, D.; Milligan, D.W. 1999: PCR-based pre-emptive therapy of cytomegalovirus infections after allogeneic stem cell transplantation with sequential intravenous ganciclovir/foscarnet and oral ganciclovir. British Journal of Haematology 105(Suppl 1): 57
Evans Strickfaden, T.; Garcia Lerma, G.; Ellerbrock, T.V.; Lennox, J.L.; Wright, T.C.; Pratt Palmore, M.; Schnell, C.; Bush, T.; Hart, C. 2001: PCR-based quantification of replication-competent HIV-1 in female genital secretions. AIDS 15(Suppl 1): S21
Yasukochi, Y. 2002: PCR-based screening for bacterial artificial chromosome libraries. Methods in Molecular Biology 192: 401-410
Hui, E.K.-W.; Wang, P.-C.; Lo, S.J. 2002: PCR-based strategies to clone unknown DNA regions from known foreign integrants. An overview. Methods in Molecular Biology 192: 249-274
Nowoslawski, L.; Murdock, C.A.; Wibbels, T. 2003: PCR-based strategy of cloning and development of a quantitative competitive RT-PCR for SOX9 in a turtle with temperature-dependent sex determination. SICB Annual Meeting and Exhibition Final Program and Abstracts : 262
Waeyenberge, L.; Madani, M.; Yu, H.; Subbotin, S.A.; Moens, M. 2002: PCR-based techniques for nematode diagnosis derived from the study of genetic diversity. Nematology 4(2): 164
Ishiguro, T. 2000: PCR-coupled activation of intercalating dyes. Kessler, Christoph Springer Lab Manuals Nonradioactive analysis of biomolecules Second Edition 631-639
Munk, C.; Morré, S.A.; Kjaer, S.K.; Poll, P.A.; Bock, J.E.; Meijer, C.J.; van den Brule, A.J. 1999: PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants. Sexually Transmitted Diseases 26(6): 325-328
Shvemberger, I.N.; Alexandrova, S.A. 2000: PCR-detected genome polymorphism in malignant cell growth. International Review of Cytology 199: 117-159
Bluhm, B.H.; Flaherty, J.E.; Woloshuk, C.P. 2002: PCR-detection of fumonisin- and trichothecene-producing Fusarium species. Phytopathology 92(6 Suppl): S8
Soultanaeva, Z.; Morozova, A.; Victorova, T.; Khusnutdinova, E. 2001: PCR-detection of the glutathione S-transferase M1 0/0 genotype in patients with iron anemia in Bashkortostan. European Journal of Human Genetics 9(Suppl 1): P1414
Viktorov, V.; Mekhdiev, D.; Timerbulatov, V. 2001: PCR-detection of the glutatione S-transferase M1 null genotype in patients with sepsis, septical shock and multiple organ failure. European Journal of Human Genetics 9(Suppl 1): P0357
Sato, M.; Sato, T.; Kojima, N.; Imai, K.; Higashi, N.; Wang, D.; Senoo, H. 2002: PCR-differential display analysis of gene expression regulated by extracellular matrix in cultured hepatic stellate cells. Cell Structure and Function 27(4): 308
Aquino, M.; Filgueiras, A.; Matos, R.; Oleastro, M.; Monteiro, L.; Santos, K.; Ferreira, M.; Teixeira, L.; Tibana, A. 2001: PCR-fingerprinting of Campylobacter jejuni and Campylobacter coli isolates by using enterobacterial repetitive intergenic consensus sequences and analyses of randomly amplified polymorphic DNA. IJMM International Journal of Medical Microbiology 291(Suppl 31): 71
Farr, G.A.; Young, D.M.; D'argenio, D.A.; Ornston, L.N. 2000: PCR-generated mutations identify essential nucleotide residues in the pcaI promoter of Acinetobacter strain ADP1. Abstracts of the General Meeting of the American Society for Microbiology 100: 440
Gründemann, D.; Censarek, P.; Schömig, E. 2003: PCR-generated truncated positive control for PCR screening of embryonic stem cell clones. Biotechniques 34(6): 1130-1132; 1134
Cloyd, M.W.; Yeh, C.C.; Chen, J. 2002: PCR-hybridization assays specific for integrated retroviruses. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)
Mirkin, C.A.; Ivanisevic, A.; Taton, T.A.; Letsinger, R.L.; Viswanadham, G. 2001: PCR-less detection of genomic DNA with nanoparticle probes. Abstracts of Papers American Chemical Society 222(1-2): INOR209
Buchheidt, D.; Baust, C.; Skladny, H.; Baldus, M.; Braeuninger, S.; Hehlmann, R. 2001: PCR-mediated detection of Aspergillus species in bronchoalveolar lavage samples of febrile neutropenic patients with acute leukemias Clinical results. Annals of Hematology 80(Suppl 2): S25
Fang, G.; Weiser, B.; Visosky, A.; Moran, T.; Burger, H. 2002: PCR-mediated recombination A general method applied to construct chimeric infectious molecular clones. Chen, Bing-Yuan , Reprint Author, Janes, Harry W , Reprint Author PCR cloning protocols: Second edition: 197-206
Chen, J.; Wen, F.; Wang, Q.; Liu, G. 2003: PCR-molecular beacon assay for detecting Mycobacterium tuberculosis in cerebrospinal fluid. Journal of Neurochemistry 87(Suppl 1): 59
Ehrbar, H.U.; Bauerfeind, P.; Dutly, F.; Koelz, H.R.; Altwegg, M. 1999: PCR-positive tests for Tropheryma whippelii in patients without Whipple's disease. Lancet 353(9171): 2214
Pasquali, M.; Gullino, M.L.; Garibaldi, A. 2003: PCR-real time identification of Fusarium oxysporum f sp basilici on basil seeds and roots. Phytopathology 93(6 Suppl): S70
Maher, M.; O'connor, L.; Joy, J.; Kane, M.; Smith, T. 1999: PCR/DNA probe membrane-based colorimetric assays for the detection of Listeria and L monocytogenes in food samples. Abstracts of the General Meeting of the American Society for Microbiology 99: 517
Kormutak, A.; Ziegenhagen, B.; Scholz, F.; Yang, J.C.uan 1999: PCR/RFLP of cpDNAs in some Abies species. Biologia 54(Suppl 7): 37-38
Akyol, O.; Canatan, H.; Yilmaz, H.R.; Yuce, H.; Ozyurt, H.; Sogut, S.; Gulec, M.; Elyas, H. 2004: PCR/RFLP-based cost-effective identification of SOD2 signal sequence polymorphism using NgoM IV a detailed methodological approach. Clinica Chimica Acta 345(1-2): 151-159
Leray, I.; Habib Jiwan, J.L.; Soumillion, J.Ph.; Valeur, B. 2000: PCT fluorescent molecular sensor for cations Effect of structure on selectivity. Luminescence 15(2): 107-109
Reith, H.B.; Mittelkoetter, U.; Wagner, R.; Thiede, A. 2000: PCT in patients with abdominal sepsis. Revue Internationale des Services de Sante des Forces Armees 73(3): 177-181
Monsma, F.J.Jr; Shen, Y.; Sibley, D.R.; Hamblin, M. 1999: PCT-65 serotonin receptor. Official Gazette of the United States Patent and Trademark Office Patents 1223(4)
Graeser, R.; Dubois, T.; Aitken, A.; Hunt, T. 2001: PCTAIRE-1, a CDK-related protein kinase involved in the regulation of neurite outgrowth. Cell Biology International 25(2): A15
Kappelle, A.C.; Postma, T.J.; Taphoorn, M.J.B.; Groeneveld, G.J.; Groeningen, C.J.; Zonnenberg, B.A.; Heimans, J.J. 1999: PCV chemotherapy useful in the treatment of recurrent glioblastoma multiforme?. Neurology 52(6 Suppl 2): A423
Allan, G.; McNeilly, F.; Krakowa, S.; Ellis, J. 2003: PCV-2 infection in swine; more than just postweaning multisystemic wasting syndrome. Veterinary Journal 166(3): 222-223
Siebel,K. 2010: PCV2 vaccination changing the pig industry Part 2 Global experiences from the field around one-shot vaccination. Pig Progress: 1, 11-13
Tandon, V.K.; Kumar, M. 2003: PCl5 and lewis acid catalysed synthesis of 2,3-disubstituted quinoxalines as non-peptide antagonists for interleukin-8 receptor. Medicinal Chemistry Research 12(6-7): 307
Chatterjee, A.; Booth, J.; Brogley, L.; Campbell, G.; Cody, W.; Geer, J.J.; He, J.; Hu, L.Y.; Lescosky, L.J.; Malone, T.; Miljanich, G.; Nadasdi, L.; Rafferty, M.F.; Rock, D.; Sercel, A.; Silva, D.; Stoehr, S. 1999: PD 151307 analogs Investigation of tyrosine modified derivatives as N-type calcium channel blockers. Abstracts of Papers American Chemical Society 217(1-2): MEDI 118
Ryder, T.R.; Hu, L.Y.; Millerman, E.; Tarczy Hornoch, K.; Szoke, B.G.; Rafferty, M.F. 1999: PD 151307 analogs Multiple parallel synthesis and biological evaluation of N,N-dialkylpeptidylamine derivatives as N-type calcium channel blockers. Abstracts of Papers American Chemical Society 217(1-2): MEDI 121
Hu, L.Y.; Ryder, T.R.; Campbell, G.W.; Dooley, D.J.; Geer, J.J.; Hom, D.; Lotarski, S.M.; Miljanich, G.P.; Millerman, E.; Rock, D.M.; Song, Y.; Stoehr, S.J.; Szoke, B.G.; Taylor, C.P.; Vartanian, M.G.; Weber 1999: PD 151307 analogs Substituted peptidylamines as novel N-type calcium channel blockers. Society for Neuroscience Abstracts 25(1-2): 1016
Hu, L.Y.; Ryder, T.R.; Campbell, G.W.; Dooley, D.J.; Geer, J.J.; Hom, D.; Lotarski, S.M.; Millerman, E.; Rafferty, M.F.; Rock, D.M.; Song, Y.; Stoehr, S.J.; Szoke, B.G.; Taylor, C.P.; Vartanian, M.G.; Weber, M.L. 1999: PD 151307 analogs Substituted peptidylamines as novel N-type calcum channel blockers. Abstracts of Papers American Chemical Society 217(1-2): MEDI 120
Hu, L.Y.; Ryder, T.R.; Nikam, S.; Millerman, E.; Szoke, B.G.; Taylor, C.P.; Rafferty, M.F. 1999: PD 151307 analogs Synthesis and biological evaluation of substituted 4- phenylalanine derivatives as novel N-type calcium channel blockers. Abstracts of Papers American Chemical Society 217(1-2): MEDI 119
Cheng, X.M.; Lee, C.; Repine, J.T.; Skeean, R.S.; Berryman, K.A.; Bunker, A.M.; Edmunds, J.J.; Doherty, A.M.; Haleen, S.J.; Shroeder, R.; Walker, D.M.; Welch, K.M.; Hallak, H. 1999: PD 180988, a potent ETA selective antagonist and its therapeutic potential. Abstracts of Papers American Chemical Society 217(1-2): MEDI 135
Jörres, A. 2003: PD: a biological membrane and a non-biological fluid. Contributions to Nephrology 140: 1-9
Chaudhuri, K.R.; Taurah, L.S.; Macmahon, D.G.; Turner, K.; Kelly, L.; Burn, D.; Forbes, A.; Bowron, A.; Foster, O.J. 2004: PD LIFE - A prospective multi-centre longitudinal audit of quality of life in Parkinsons disease across the UK. Journal of Neurology Neurosurgery and Psychiatry 75(3): 516-517
Sothinathan, R.; Eustace, J.A.; Krishnan, M.; Kuhn, D.; Moore, R.; Scheel, P.J. 2000: PD catheter survival and infection rate in HIV seropositive patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 220A
Trimmer, P.A. 1999: PD cybrids contain inclusion bodies that share antigenic determinants with Lewy bodies. Society for Neuroscience Abstracts 25(1-2): 1336
Hyatt, J.M.; Mangione, S.; Schentag, J.J. 1999: PD modeling of three chemotherapeutic agents and human lung tumor cells. Clinical Pharmacology and Therapeutics 65(2): 198
Macgowan, A.P. 2001: PD prediction of outcomes, bacterial eradication and resistance emergence Relevance to therapy. Journal of Antimicrobial ChemoTherapy 47(Suppl S1): 11
L.P.ole, C.Y.; Van Ittersum, F.J.; Valentijn, R.M.; Ter Wee, P.M.; Schalkwijk, C. 2003: PD regimen contributes to the blood concentration of glucose degradation products in new CAPD patients. Journal of the American Society of Nephrology 14(Abstracts Issue): 478A
Sakai, K.; Iwamoto, M.; Kadomatsu, S.; Mizuiri, S.; Hasegawa, A. 2001: PD selection and residual renal function are determined by referral pattern in patients requiring dialysis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 346A
Klugewitz, C.; Kulendik, V.; Heise, J.; Klofat, R.; Schott, G.; Bach, D. 2001: PD treatment with GAVE Syndrome Argonplasma coagulation as a possibility to maintain the mode of renal replacement therapy. Kidney and Blood Pressure Research 24(4-6): 303
Nishimura, H.; Honjo, T. 2001: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends in Immunology 22(5): 265-268
Blazar, B.R.; Carreno, B.M.; Panoskaltsis Mortari, A.; Carter, L.J.; Iwai, Y.; Yagita, H.; Nishimura, H.; Taylor, P.A. 2002: PD-1 Engagement Provides an Inhibitory Signal Which Downregulates T Cell Alloresponses In Vivo. Blood 100(11): Abstract No. 261
Nishimura, H.; Nose, M.; Hiai, H.; Minato, N.; Honjo, T. 1999: PD-1 is involved in the regulation of autoimmune diseases by negatively controlling various immunocompetent lineage cells. Journal of Autoimmunity (Suppl ): 39
Fox, M.A.; Fuss, B. 2002: PD-Ialpha/ATX-stimulated counter-adhesion of oligodendrocytes on fibronectin substrates is developmentally regulated and requires functionally active beta3 integrin. Molecular Biology of the Cell 13(Suppl): 204a-205a
Latchman, Y.; Wood, C.; Chernova, T.; Iwai, Y.; Malenkovich, N.; Long, A.; Bourque, K.; Boussiotis, V.; Nishimura, H.; Honjo, T.; Sharpe, A.; Freeman, G. 2001: PD-L2, a novel B7 homologue, is a second ligand for PD-1 and inhibits T cell activation. FASEB Journal 15(4): A345
Schwertz, H.; Abudureheman, M.; Laengin, T.; Darius, H.; Werdan, K.; Buerke, M. 2003: PD1639016 reduces myocardial ischemia-reperfusion injury by inhibition of the p38 MAP kinase pathway. FASEB Journal 17(4-5): Abstract 150
Wolff, N.C.; Veach, D.R.; Tong, W.P.; Bornmann, W.G.; Clarkson, B.; Ilaria, R.L.J. 2003: PD166326, a novel tyrosine kinase inhibitor, has greater anti-leukemic activity than imatinib in a murine model of chronic myelogenous leukemia. Blood 102(11): 31a
Poeck, H.; Wagner, M.; Wellisch, D.; Kerkmann, M.; Sarris, A.; Battiany, J.; Stuplich, M.; Rothenfusser, S.; Endres, S.; Hartmann, G. 2003: PDC support CpG-induced B cell activation and plasma cell generation via direct cell-to-cell contact and soluble factors. FASEB Journal 17(7): C311
Gwathmey, T.M.; Ignotz, G.G.; Suarez, S.S. 2002: PDC-109 enables epididymal bull sperm to bind to oviductal epithelium. Journal of Andrology Suppl (Suppl): 29
Gwathmey, T.M.; Ignotz, G.G.; Suarez, S.S. 2001: PDC-109 mediates the binding of bovine sperm to oviductal epithelium. Biology of Reproduction 64(Suppl 1): 112
Griffith, T.S.; Kemp, T.J.; Elzey, B.D. 2003: PDC-derived IFN-a induces TRAIL/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation. FASEB Journal 17(7): C74
Freyne, E.J. Edgard; Fernandez Gadea, F.J.; Andres Gil, J.I. 2000: PDE IV inhibiting 2-cyanoiminoimidazole derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1233(3)
Friesen, R.; Ducharme, Y.; Dube, D.; Girard, Y.; Frenette, R.; Li, C.; Blouin, M.; Chauret, N.; Trimble, L. 2001: PDE IV inhibiting compounds, compositions and methods of treatment. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)
Freyne, E.J.; Diels, G.S.; Matesanz Ballesteros, M.E.; Diaz Martinez, A. 2003: PDE IV inhibiting pyridine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)
Macinnes, A.; Timmons, J.A. 2002: PDE inhibition by UK-114,542 does not alter skeletal muscle function during partial ischaemia in the anaesthetised dog. Journal of Physiology (Cambridge) 539P: 47P-48P
Bielekova, B.; Lincoln, A.; Mcfarland, H.; Martin, R. 1999: PDE inhibitors as an emerging therapy of multiple sclerosis Comprehensive preclinical analysis of their effects on human immune cells. Neurology 52(6 Suppl 2): A560
Hassell, K.A.; Dessauer, C.W.; Rich, T.C. 2004: PDE type 4 regulates basal cAMP levels in cultured vascular smooth muscle cells. Biophysical Journal 86(1): 229a
Brock, G.B.; Deyoung, L.; Yu, D.; Freeman, D. 2003: PDE-5 inhibitor treatment failure in diabetics may be salvaged with antioxidants. Journal of Urology 169(4 Suppl): 352
Wilkes, N.; White, S.; Rajasekaran, M. 2003: PDE-V inhibition synergizes Rho-kinase antagonism and enhances erectile response in male hypertensive rats. Journal of Urology 169(4 Suppl): 360-361
Novalija, E.; Varadarajan, S.; An, J.Z.; Stowe, D.F. 2000: PDE-V inhibitor zaprinast enhances relaxation and cGMP levels by nitroprusside in guinea pig aortic rings. FASEB Journal 14(4): A664
Mata, M.; Sarria, B.; Cortijo, J.; Morcillo, E.J. 2002: PDE4 inhibition decreases MUC5AC expression in human cultured airway epithelial cells. Methods and Findings in Experimental and Clinical Pharmacology 24(Suppl A): 136
Martin Chouly, C.A.E.; Astier, A.; Jacob, C.; Pruniaux, M.P.; Bertrand, C.; Lagente, V. 2003: PDE4 inhibitor CI-1044 inhibits TNF-alpha-induced release of MMP-2 from human lung fibroblasts. Inflammation Research 52(Suppl 2): S 167
Cheng, J.; Gray, C.E.; Warner, G.M.; Grande, J.P. 2003: PDE4 inhibitors suppress TGF-beta stimulated MCP-1 expression in mesangial cells by decreasing message stability. Journal of the American Society of Nephrology 14(Abstracts Issue): 170A-171A
Grande, J.P.; Cheng, J.; Warner, G.M.; Gray, C.E. 2003: PDE4 inhibitors suppress TGF-beta-stimulated MCP-1 expression by mesangial cells. FASEB Journal 17(4-5): Abstract 160
Muellershausen, F.; Friebe, A.; Feil, R.; Hofmann, F.; Koesling, D. 2003: PDE5 as a regulator of NO/cGMP-mediated signal transduction. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R45
Bivalacqua, T.J.; Champion, H.C.; Takimoto, E.; Kass, D.; Burnett, A.L. 2004: PDE5 dysregulation in penile erectile tissue Mechanism of priapism. Journal of Urology 171(4 Suppl): 375
Belardi, D.F.; Takimoto, E.; Kass, D.A. 2002: PDE5 inhibition blunts beta-adrenergic response in NOS3 intact but not NOS3-null murine myocytes without altering calcium transients. Circulation 106(19): II23
Dukarm, R.C.; Steinhorn, R.H.; Russell, J.A.; Gugino, S.F.; Wang, H.; Cummings, J.J. 1999: PDE5 inhibition with E4021 affects the pulmonary vasculature and lung liquid production in near term fetal lambs. Pediatric Research 45(4 Part 2): 301A
Beavo, J.A.; Li, L. 1999: PDE7A1, a possible target for treatment of inflammatory diseases. Abstracts of Papers American Chemical Society 217(1-2): MEDI 266
Mcmahon, C.; Yang, L.Y.; Kitching, R.; Kahn, H.; Seth, A. 2002: PDEF, an ETS family transcription factor overexpressed in breast tumors and breast cancer patient blood samples. Breast Cancer Research and Treatment 76(Suppl 1): S104
Ambrosino, G.; Cillo, U.; Varotto, S.; Basso, S.; Konthotanassis, D.; Montin, U.; Bettiol, M.; Carraro, P.; Turioni, B.; Feltracco, P.; Boccagni, P.; Brolese, A.; Zanus, G.; Fagiuoli, S.; Plebani, M.; D'amico, D. 2001: PDF post liver transplant treated by MARS Case report. Cell Transplantation 10(6): 552
Filiberti, R.; Ardizzoni, A.; Bobbio, B.; Ivaldi, G.P.; Marroni, P.; Neri, M.; Puntoni, R.; Ricci, I.; Paganuzzi, M. 2000: PDGF A-B concentration in serum of patients with lung cancer or pleural mesothelioma and in controls. Tumori 86(4 Suppl 1): 67-68
Sakagami, K.; Kodama, T.; Puro, D.G. 2000: PDGF activates ion channels in adult retinal pericytes. IOVS Investigative Ophthalmology and Visual Science 41(4): S634
Caligiuri, A.; Carloni, V.; Defranco, R.M.S.; Sciammetta, S.C.; Gentilini, A.; Sali, C.; Gentilini, P.; Pinzani, M. 2000: PDGF activation of MAP kinase requires focal adhesion kinase/c-Src complex formation in human hepatic stellate cells. Journal of Hepatology 32(Suppl 2): 47
Mori, S. 1999: PDGF and PDGF receptors. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 36(7): 457-465
Raines, E.W. 2004: PDGF and cardiovascular disease. Cytokine and Growth Factor Reviews 15(4): 237-254
Zhang, P.; Cui, X.; Hadsell, D.L.; Oesterreich, S.; Lee, A.V. 2001: PDGF decreases insulin receptor substrate levels via PI3K-mediated proteasomal degradation. Breast Cancer Research and Treatment 69(3): 235
Peterson, T.E.; Abe, J.; Kleppe, L.S.; Mueske, C.S.; Simari, R.D. 2000: PDGF downregulates caveolin-1 protein expression in human VSMC via A c-SRC dependent mechanism. Journal of Submicroscopic Cytology and Pathology 32(3): 454
Mcavoy, J.W.; Kok, A.; Chamberlain, C.G.; Lovicu, F.J. 1999: PDGF induces proliferation and potentiates FGF-induced fibre differentiation in lens epithelial explants. IOVS Investigative Ophthalmology and Visual Science 40(4): S516
Chao, J.T.; Ramos, K.S.; Wilson, E. 2004: PDGF modulates alpha 7 integrin expression in vascular smooth muscle cell. FASEB Journal 18(4-5): Abstract 623
Yi, B.; Williams, P.J.; Niewolna, M.; Yoneda, T. 2000: PDGF produced in breast cancer promotes osteosclerotic bone metastases. Journal of Bone and Mineral Research 15(Suppl 1): S147
Park, J.S.; Lee, J.J.; Paik, K.S.; Yeon, D.S. 1999: PDGF promotes proliferation of dopaminergic neurons derived from neuronal progenitor cells. Society for Neuroscience Abstracts 25(1-2): 2043
Kawada, N.; Matsui, H.; Imanishi, Y. 2004: PDGF receptor as a molecular target of antioxidants in stellate cell. Journal of Hepatology 40(Suppl 1): 96-97
Murray, J.P.; Peppel, K.; Freedman, N.J. 2000: PDGF receptor desensitization by G protein-coupled receptor kinase-2. Circulation 102(18): 2; 274
Lemström, K.; Sihvola, R.; Tikkanen, J.; Aaltola, E.; Buchdunger, E.; Laitinen, O.; Koskinen, P. 2001: PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits. TransplantationProceedings 33(1-2): 318
Levitzki, A. 2004: PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine and Growth Factor Reviews 15(4): 229-235
Levitzki, A.; Gazit, A.; Banai, S.; Gertz, D.S.; Golomb, G. 1999: PDGF receptor kinase inhibitory compounds their preparation and compositions. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)
Levitzki, A.; Gazit, A.; Banai, S.; Gertz, S.D.; Golomb, G.; Boehmer, F.D.; Waltenberger, J. 2002: PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)
Parvani, J.G.; Brian, L.; Murray, J.P.; Peppel, K.; Freedman, N.J. 2001: PDGF receptor phosphorylation and desensitization by G protein-coupled receptor kinase-2. Circulation 104(17): 2; 62
Pietras, K.; Sjöblom, T.; Rubin, K.; Heldin, C.-H.; Ostman, A. 2003: PDGF receptors as cancer drug targets. Cancer Cell 3(5): 439-443
Leppanen, O.; Shimizu, A.; Sjoblom, T.; Pietras, K.; Rubin, K.; Buchdunger, E.; Jancic, N.; Heldin, C.H.; Ostman, A. 2000: PDGF receptors as drug targets for treatment of cancer and restenosis. International Journal of Molecular Medicine 6(Suppl 1): S53
Ostman, A. 2004: PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine and Growth Factor Reviews 15(4): 275-286
Kwon, Y.nhee Kim; Hwang, Eunmi; Hong, Hunseok 1999: PDGF reduced neuronal cell death in rat hippocampal stem cell line. Society for Neuroscience Abstracts 25(1-2): 1528
Gilbert, R.E.; Kelly, D.J.; Mckay, T.; Chadban, S.; Hill, P.A.; Cooper, M.E.; Atkins, R.C.; Nikolic Paterson, D.J. 2000: PDGF signal transduction inhibition ameliorates mesangial proliferative glomerulonephritis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 506A
Tallquist, M.; Kazlauskas, A. 2004: PDGF signaling in cells and mice. Cytokine and Growth Factor Reviews 15(4): 205-213
Soriano, P. 2001: PDGF signaling in mouse development. Developmental Biology 235(1): 172
Mckinnon, R.D.; Dunbar, M.; Rao, H.; Wu, I.; Ebner, S. 2000: PDGF signaling specificity and context in O2A progenitors. Journal of Neurochemistry 74(Suppl ): S54
Ding, Q.; Rhoden, R.; Stewart, J.; Gladson, C. 2001: PDGF stimulated Src kinase activity preferentially associates with integrin alpha V beta 3 in glioma cells and promotes cell migration. Proceedings of the American Association for Cancer Research 42: 171
Yoshizumi, M.; Izawa, Y.; Suzaki, Y.; Kyaw, M.; Ali, N.; Fujita, Y.; Tsuchiya, K.; Tamaki, T. 2003: PDGF stimulates big mitogen-activated protein kinase 1 in vascular smooth muscle cells. Circulation 108(17): IV25
Siegfried, G.; Benjannet, S.; Heldi, C.H.; Khatib, A.M.; Seidah, N.G. 2002: PDGF-A and PDGF-B processing by the proprotein convertases furin and/or PC5 is required for their receptor Tyr-phosphorylation. Proceedings of the American Association for Cancer Research 43: 830
Redman, R. 2001: PDGF-A and TGF-beta in diabetes-accelerated atherosclerosis. Journal of Investigative Medicine 49(1): 87A
Dobrian, A.D.; Wade, S.S.; Prewitt, R.L. 1999: PDGF-A expression correlates with blood pressure and arterial remodeling in hypertensive rats. FASEB Journal 13(4 Part 1): A43
Zhang, P.J.; Goldblum, J.R.; Pawel, B.R.; Pasha, T.L.; Fisher, C.; Barr, F.G. 2002: PDGF-A, PDGF-Rbeta, TGFbeta3 and bone morphogenetic protein 4 in desmoplastic small round cell tumors with EWS-WT1 gene fusion product and their role in stromal desmoplasia. Laboratory Investigation 82(1): 24A
Leeb, S.N.; Rogler, G.; Vogl, D.; Straub, R.H.; Falk, W.; Scholmerich, J.; Gelbmann, C.M. 2000: PDGF-AB and other protein factors induce migration of primary intestinal myofibroblasts. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A799
Tang, L.; Chazen, J.L.; Meeus, S.; Jacobson, J.; Nahirney, P.; Christini, D.J.; Rafii, S.; Edelberg, J.M. 2002: PDGF-AB mediates the cardioplastic potential of adult bone marrow cells Restoration of cardiac myocyte derivation from aging bone marrow. Circulation 106(19): II11
Leeb, S.N.; Vogl, D.; Falk, W.; Schoelmerich, J.; Rogler, G.; Gelbmann, C.M. 2002: PDGF-AB, IGF-I, EGF and TGF-beta1 stimulate the migration of human colonic myofibroblasts. Gastroenterology 122(4 Suppl 1): A-249
Hoppe, J.; Weich, H. 1999: PDGF-AB, preparation process and pharmaceuticals containing them. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Van Roeyen, C.R.C.; Thieltges, S.R.; Martinkus, S.; Ostendorf, T.; Bokemeyer, D.; Floege, J.; Mertens, P.R. 2003: PDGF-B down-stream signaling involves YB-1 activation in mesangioproliferative glomerulonephritis. Journal of the American Society of Nephrology 14(Abstracts Issue): 62A
Czochra, P.; Garcia Lazaro, J.F.; Thieringer, F.R.; Meyer, E.; Friebe, D.; Blessing, M.; Galle, P.R.; Lohse, A.W.; Kanzler, S. 2004: PDGF-B has profibrogenic activity in the liver-studies on a transgenic mouse model with liver specific overexpression of PDGF-B. Journal of Hepatology 40(Suppl 1): 95
Fujisawa, K.; Spee, C.; He, S.; Hinton, D.R.; Ryan, S.J. 2001: PDGF-BB and TGFbeta play an important role in the progression of PVR in a new mouse model. IOVS Investigative Ophthalmology and Visual Science 42(4): S809
Kagami, S.; Urushihara, M.; Kondo, S.; Yasutomo, K.; Kitamura, M.; Loster, K.; Kuroda, Y. 2001: PDGF-BB enhances alpha1beta1 integrin-mediated activation of ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 706A-707A
Kaplan Albuquerque, N.; Garat, C.; Bogaert, Y.; Nemenoff, R.A. 2002: PDGF-BB induced suppression of smooth muscle specific gene expression is mediated by AKT activation in vascular smooth muscle cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 89A
Breitkopf, K.; Sawitza, I.; Gressner, A.M. 2003: PDGF-BB induces thrombospondin-1 expression in a Src-dependent manner leading to activation of latent TGF-beta in hepatic stellate cells. Hepatology 38(4 Suppl 1): 775A
Zeller, P.J.; Skalak, T.C.; Price, R.J. 1999: PDGF-BB is chemotactic for fibroblasts in a novel in vivo mesentery cell migration assay. FASEB Journal 13(4 Part 1): A7
Braun, M.; Weber, A.A.; Zimmermann, N.; Schroer, K. 1999: PDGF-BB stimulates nuclear translocation of NFkB in human vascular smooth muscle cells without degradation of IkB A novel mechanism of NFkB activation?. European Heart Journal 20(ABSTR Suppl ): 358
Stehr, M.; Adam, R.M.; Khoury, J.; Zhuang, L.; Solomon, K.R.; Peters, C.A.; Freeman, M.R. 2002: PDGF-BB stimulates ureteral smooth muscle cells through caveolin-enriched lipid rafts. Journal of Urology 167(4 Suppl): 35
Krishnan, G.V.; Na, S.; Hammond, L.; Glasebrook, A.; Yeh, W.; Myers, L.; Kharitonenkov, A.; Su, E.W.; Song, H.; Geiser, A.G.; Ma, Y.L.; Zeng, Q.; Black, E.C.; Frolik, C.A. 2001: PDGF-CC a novel gene that exhibits bone anabolic activity. Journal of Bone and Mineral Research 16(Suppl 1): S251
Reeves, H.L.; Thompson, M.G.; Dack, C.L.; Burt, A.D.; Day, C.P. 1999: PDGF-induced HSC proliferation A role for prolonged activation of ERK by phosphatidic acid. Journal of Hepatology 30(Suppl 1): 92
Von Eicken, J.; Denk, P.O. 2001: PDGF-induced downregulation of PDGF-receptor type beta in human Tenons capsule fibroblasts. IOVS Investigative Ophthalmology and Visual Science 42(4): S548
Smith, C.M.; Alberta, J.A.; Liu, W.; Stiles, C.D.; Williams, B.P. 1999: PDGF-regulated genes involved in neuronal development. Society for Neuroscience Abstracts 25(1-2): 1029
Mogford, J.E.; Mustoe, T.A. 2001: PDGF-stimulated migration of human dermal fibroblasts in 3-D collagen gels is reduced with age and hypoxia. Wound Repair and Regeneration 9(2): 153-154
Choudhury, G.Ghosh 2001: PDGF-stimulated phosphatidylinositol 3 kinase target Akt regulates forkhead transcription factor and p27kip1 cyclin kinase inhibitor gene transcription in mesangial cells A potential role in regulation of PDGF-induced DNA synthesis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 588A
Monga, D.K.; Hussain, S.; Sneddon, T.; Tan, X.; Michalopoulos, G.K.; Monga, S.P.l S. 2003: PDGFR-alpha and IGFBP5 upregulation in early liver development and tumor cells. Proceedings of the American Association for Cancer Research 44: 267
Corless, C.L.; Heinrich, M.C.; Duensing, A.; Mcgreevey, L.; Chen, C.J.; Joseph, N.; Singer, S.; Griffith, D.J.; Haley, A.D.; Town, A.; Demetri, G.D.; Fletcher, C.D.M.; Fletcher, J.A. 2003: PDGFRA and KIT gain-of-function mutations are alternative oncogenic mechanisms in gastrointestinal stromal tumors. Proceedings of the American Association for Cancer Research 44: 881-882
Fiory, F.; Esposito, I.; Alberobello, T.; Oriente, F.; Santopietro, S.; Valentino, R.; Giacco, F.; Beguinot, F.; Formisano, P. 2003: PDK1 interaction with insulin receptor and tyrosine phosphorylation are required for insulin metabolic action. Diabetologia 46(Suppl 2): A40
Mora, A.; Komander, D.; van Aalten, D.M.F.; Alessi, D.R. 2004: PDK1, the master regulator of AGC kinase signal transduction. Seminars in Cell and Developmental Biology 15(2): 161-170
Cohen, P.; Williams, M.; Alessi, D.R. 2000: PDK1, the missing link in insulin signal transduction. Biochemical Society Transactions 28(5): A142
Hiraoka, D.; Hori, S.; Fukuhara, T.; Tachibana, K.; Okumura, E.; Kishimoto, T. 2003: PDK1-Akt pathway is required for meiotic reinitiation. Cell Structure and Function 28(4): 289
Partovian, C.; Simons, M. 2003: PDK2 activity of protein kinase Calpha Regulation of protein kinase B/Akt activity in endothelial cells. Circulation 108(17): IV3
Nordsborg, N.; Krustrup, P.; Klarskov, C.; Bangsbo, J.; Pilegaard, H. 2002: PDK4, PFK and HKII transcription responds in different ways to high-intensity intermittent training. FASEB Journal 16(4): A447
Rosenbauer, F.; Wagner, K.; Zhang, P.; Knobeloch, K.-P.; Iwama, A.; Tenen, D.G. 2004: PDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. Blood 103(11): 4294-4301
Hanisch, P.H.; Furre, T.; Olsen, D.R.; Pettersen, E.O. 2000: PDR A mosaic pattern of dose rate dependent variables. Radiotherapy and Oncology 56(Suppl 1): S101-S102
Johansson, B.; Reizenstein, J.; Karlsson, L.; Gertzen, H.; Nilsson, C.; Westerborn, A. 2000: PDR fractionation, both a matter of radiobiology and practical logistics Experience of every second hour pulsing in Head and Neck cancers. Radiotherapy and Oncology 56(Suppl 1): S104
Lee, J.H.; Wu, T.; Everett, L.A.; Royaux, I.E.; Green, E.D.; Marcus, D.C. 2002: PDS gene knockout abolishes transmural voltage but not potassium secretion in the cochlea. FASEB Journal 16(4): A425
Lopez Bigas, Nuria; Rabionet, R.; De Cid, R.; Govea, N.; Gasparini, P.; Zelante, L.; Estivill, X. 1999: PDS mutations in Spanish and Italian families with Pendred syndrome. European Journal of Human Genetics 7(Suppl 1): 60
Schmidt, S.; Wagner, U. 2000: PDT for cytoreduction in cases of ovarian cancer. Wyss, Pius Author, Tadir, Yona Author, Tromberg, Bruce Journal Author, Haller, Urs Author Photomedicine in gynecology and reproduction 296-301
Tap Study Group; Levy, J. 1999: PDT in the treatment of ocular neovasculature. Photochemistry and Photobiology 69(SPEC ISSUE ): 48S
Stammers, A.T.; Choy, J.C.H.; Hasan, M.; Tao, J.S.; Levy, J.G.; Margaron, P. 1999: PDT modulates chemokine and cytokine secretion from endothelial cells. Photochemistry and Photobiology 69(SPEC ISSUE ): 10S
Kenney, M.E.; Li, Y.S.; Oleinick, N.L.; Mukhtar, H.; Rodgers, M.A.J. 1999: PDT structure-activity study of two homologous series of compounds related to Pc 4. Photochemistry and Photobiology 69(SPEC ISSUE ): 38S
Asagami, T.; Tsao, P.S. 1999: PDTC inhibits monocyte adhesion in apoE-knockout mice. Circulation 100(18): 1; 13
Arantes, V.C.A.; Teixeira, V.P.A.; Leite, A.R.; Reis, M.A.B.; Latorraca, M.Q.; Carneiro, E.M.; Yamada, A.T.; Boschero, A.C. 2002: PDX-1 expression in pancreatic islets from malnourished rats. Diabetologia 45(Suppl 2): A 148
Halkin, A.; Ber, I.; Cohen, H.; Einav, Y.; Goldberg, I.; Barshack, I.; Seijffers, R.; Kopolovic, J.; Kaiser, N.; Karasik, A.; Ferber, S. 2000: PDX-1 extends the beta-cell phenotype to liver, in-vivo. Diabetologia 43(Suppl 1): A58
Ber, I.; Shternhall, K.; Perl, S.; Ferber, S. 2003: PDX-1 induces wide and long lasting liver to pancreas trans-differentiation, and induces its own expression in liver, in-vivo. Diabetes 52(Suppl 1): A358
Wang, Z.; Sibley, E. 2003: PDX-1 interacts with the lactase promoter and functions as a repressor Role in specifying anterior gut spatial restriction. Pediatric Research 53(4 Part 2): 166A-167A
Brissova, M.; Spear, C.; Nicholson, W.; Shiota, M.; Chu, A.; Wright, C.V.; Charron, M.J.; Powers, A.C. 2001: PDX-1 reduction impairs islet response to insulin resistance and leads to diabetes. Diabetes 50(Suppl 2): A337
Yoshida, S.; Kajimoto, Y.; Fujitani, Y.; Umayahara, Y.; Watada, H.; Matsuhisa, M.; Yamasaki, Y.; Hori, M. 2001: PDX-1-transfected intestinal epithelial cells produce insulin under renal capsules. Diabetes 50(Suppl 2): A6
Li, Y.; Li, J.; Straight, S.W.; Kershaw, D.B. 2002: PDZ domain mediated interaction of rabbit podocalyxin and NHERF-2. Pediatric Research 51(4 Part 2): 427A-428A
Fujii, M.; Hirata, A.; Higuchi, M.; Endo, K.M.; Takahashi, T.M.; Ohashi, M.M.; Niinuma, A. 2003: PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the transformation of a rat fibroblast cell line. AIDS Research and Human Retroviruses 19(Suppl): S-21
Bezprozvanny, I.; Maximov, A. 2002: PDZ domains Evolving classification. FEBS Letters 512(1-3): 347-349, 13 February
Vaccaro, P.; Dente, L. 2002: PDZ domains: troubles in classification. Febs Letters 512(1-3): 345-349
Kay, B.K.; Kehoe, J.W. 2004: PDZ domains and their ligands. Chemistry and Biology 11(4): 423-425
Spiers, A.; Lamb, H.K.; Cocklin, S.; Wheeler, K.A.; Budworth, J.; Dodds, A.L.; Pallen, M.J.; Maskell, D.J.; Charles, I.G.; Hawkins, A.R. 2002: PDZ domains facilitate binding of high temperature requirement protease A and tail-specific protease to heterologous substrates through recognition of the small stable RNA A -encoded peptide. Journal of Biological Chemistry 277(42): 39443-39449
Garner, C.C.; Nash, J.; Huganir, R.L. 2000: PDZ domains in synapse assembly and signalling. Trends in Cell Biology 10(7): 274-280
Eldstrom, J.; Steele, D.; Fedida, D. 2002: PDZ domains of PSD-95 binds to both the C- and N-termini of the voltage-gated potassium channel Kv15. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S277
Rizzolo, L.J.; Peng, S.; Wilt, S.D. 2001: PDZ domains of ZO-2 modulate RPE tight junctions. IOVS Investigative Ophthalmology and Visual Science 42(4): S751
Ramsey, I.S.; Delling, M.; Clapham, D.E. 2004: PDZ interactions control subcellular localization of the temperature-sensitive channel TRPV3. Biophysical Journal 86(1): 258a
Dehmelt, L.; Nalbant, P.; Hagnia, M.; Huelseweh, B.; Werner, A. 1999: PDZ-domain interaction of the Na/Pi cotransporter type II. FASEB Journal 13(7): A1493
Stanton, Bruce Alan 2001: PDZ-mediated interactions retain CFTR in the apical plasma membrane of polarized epithelial cells. FASEB Journal 15(4): A141
Kocher, O.N. 2000: PDZK1 protein containing PDZ interaction domains. Official Gazette of the United States Patent and Trademark Office Patents 1232(4)
Visintini, R.; Catalano, R.; Campanini, E. 2000: PDs functioning and therapeutic indications When and how the group heals. European Psychiatry 15(Suppl 1): 63-64
Olszowy, M.W.; Mcchesney, J.L.; Burroughs, P.M.; Johnson, H. 2004: PE-Alexa Fluor 610, a bright new tandem fluorophore devoid of artifactual B cell binding in NOD mice. Cytometry 59A(1): 147
Wolosin, J.M.; Schutte, M.; Candia, O.A.; Shi, X.P.; Tieng, A. 1999: PE-to-NPE calcium gradients causes internalization of the ciliary body heterocellular apical gap junctions. IOVS Investigative Ophthalmology and Visual Science 40(4): S498
Hung, M.C.; Xing, X. 1999: PEA3 is a tumor suppressor. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)
Liu, Y.; Borchert, G.; Phang, J.M. 2003: PEA3, an Ets transcriptional factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. Proceedings of the American Association for Cancer Research 44: 1042-1043
Gorelick, M.; Cronan, K.; Kost, S.; Palmer, K. 2000: PEAT Pediatric emergency assessment tool. Pediatric Research 47(4 Part 2): 107A
Woolkalis, M.J.; Salva, S.M.; Hollinger, M.K.; Ukropec, J.A. 1999: PECAM association with SHP2 and PTP1B in human endothelial cells. FASEB Journal 13(4 Part 1): A530
Dasgupta, B.; Wang, Y.; Muller, W.A. 2002: PECAM signaling during transendothelial migration. FASEB Journal 16(4): A597
Sun, J.; O'brien, C.D.; Bennett, J.S.; Albelda, S.M. 2000: PECAM-1 -mediated homophilic cell-cell adhesion is regulated by outside-in signaling and is dependent on interactions with the actin cytoskeleton. FASEB Journal 14(4): A458
Lassila, R.; Olsson, E.; Bohling, T.; Sarlomo Rikala, M. 2002: PECAM-1 Expression Is Absent in Adherent Platelets but Present in Grown Thrombi of Failing Human Microvascular Anastomosis. Blood 100(11): Abstract No. 3940
Ilan, N.; Madri, J.A. 2003: PECAM-1: old friend, new partners. Current Opinion in Cell Biology 15(5): 515-524
Burns, A.R.; Gagen, D.; Murphy, A.; Zheng, Z.; Bowden, R.A.; Smith, C.W.; Rumbaut, R.E. 2003: PECAM-1 a novel regulator of neutrophil transendothelial migration velocity and endothelial barrier function. FASEB Journal 17(4-5): Abstract 758
Thompson, R.D.; Larbi, K.Y.; Duncan, G.S.; Mak, T.W.; Nourshargh, S. 2000: PECAM-1 deficient mice demonstrate a cytokine specific role for PECAM-1 in leukocyte migration. FASEB Journal 14(4): A287
Solowiej, A.; Ilan, N.; Graesser, D.; Biswas, P.; Madri, J.A. 2002: PECAM-1 deficient mice exhibit attenuated foreign-body inflammation An endothelial phenotype. FASEB Journal 16(4): A597
Ensminger, S.M.; Spriewald, B.M.; Steger, U.; Duncan, G.S.; Morris, P.J.; Mak, T.W.; Wood, K.J. 2002: PECAM-1 expression on donor endothelial cells attenuates transplant arteriosclerosis in aortic allografts. Journal of Heart and Lung Transplantation 21(1): 164-165
Kuwata, S.; Morio, T.; Yamami, A.; Takao, K.; Horikawa, T.; Arai, T.; Morio, K. 2001: PECAM-1 gene polymorphisms in membranous nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 112A
Schenkel, A.R.; Chen, X.; Liebman, R.M.; Haenel, P.U.; Muller, W.A. 2000: PECAM-1 independent transendothelial migration. FASEB Journal 14(4): A287
Newton Nash, Debra, K. 2000: PECAM-1 inhibits T cell synthesis and secretion of interleukin-2. Scandinavian Journal of Immunology 52(3): 329
Wojciechowski, J.C.; Sarelius, I.H. 2004: PECAM-1 is Expressed at both Endothelial Cell Junction and Endothelial Cell Body Surface Regions in the Lumen of Mouse Cremaster Muscle Venules and is Attenuated during the Inflammatory Response in situ. FASEB Journal 18(4-5): Abstract 430
Neubauer, K.; Wilfling, T.; Arnbrust, T.; Knittel, T.; Ramadori, G. 1999: PECAM-1 is expressed in liver sinusoids by sinusoidal endothelial cells and by Kupffer cells. Journal of Hepatology 30(Suppl 1): 91
Baumann, C.I.; Bailey, A.S.; Li, W.; Yoder, M.C.; Fleming, W.H. 2003: PECAM-1 is expressed on long term repopulating stem cells and defines a population of bone marrow cells that radioprotects but does not provide hematopoietic reconstitution. Blood 102(11): 821a
O'brien, C.D.; Ji, G.J.; Sun, J.; Wang, Y.X.; Kotlikoff, M.; Albelda, S.M. 2000: PECAM-1 on HUVEC and transfected REN cells activates a nonselective cation conductance independently regulated by the cytoplasmic ITIM and transmembrane domains. Journal of Investigative Medicine 48(2): 199A
Larbi, K.Y.; Dangerfield, J.P.; Dewar, A.; Nourshargh, S. 2002: PECAM-1 regulates expression of alpha6beta1 on transmigrated neutrophils in vivo. FASEB Journal 16(4): A597
Ilan, N.; Gratzinger, D.; Cheung, L.; Pinter, E.; Madri, J.A. 2000: PECAM-1 serine/threonine phosphorylation modulates PECAM-1/gamma-catenin association. FASEB Journal 14(4): A450
Woolkalis, M.J.; Stalker, T.J.; Kenney, J.P. 2001: PECAM-1 serves as a scaffolding protein for signaling molecules in human endothelial cells. FASEB Journal 15(4): A451
Rathore, V.B.; Hillery, C.; Wang, D.; Montgomery, R.R.; Newman, P.J. 2002: PECAM-1, but Not PLCgamma2, Regulates GPIb/V/IX-Induced Aggregation of Murine Platelet. Blood 100(11): Abstract No. 1835
Masuda, M. 2004: PECAM-1/CD31 acts as a mechanotransducer in vascular endothelial cells. Journal of Pharmacological Sciences 94(Suppl 1): 68P
Biswas, P.; Schoenfeld, J.; Madri, J.A. 2002: PECAM-1/beta-catenin interaction Identification of the region of PECAM-1 involved in beta-catenin binding. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 337A
Scherpereel, A.P.; Harshaw, D.W.; Wiewrodt, R.; Christofidou Solomidou, M.; Haut, E.; Nakada, M.; Albelda, S.M.; Muzykantov, V.; Rome, J. 2000: PECAM-directed immunotargeting of active reporter enzyme to the heart. Circulation 102(18): 2; 188
Vigliotta, G.; Miele, C.; Santopietro, S.; Perfetti, A.; Romano, C.; Valentino, R.; Formisano, P.; Beguinot, F. 2003: PED gene overexpression impairs insulin action and secretion and glucose tolerance. Diabetes 52(Suppl 1): A315
Condorelli, G.; Trencia, A.; Vigliotta, G.; Perfetti, A.; Goglia, U.; Formisano, P.; Beguinot, F. 2001: PED/PEA-15 expression inhibits stress signaling pathways. Diabetes 50(Suppl 2): S298
Hutchings, H.; Tombran Tink, J.; Mrazek, D.; Plouet, J. 1999: PEDF potentiates FGF and VEGF angiogenic and cell survival activity. IOVS Investigative Ophthalmology and Visual Science 40(4): S230
Wohabrebbi, A.; Tombran Tink, J.; Mrazek, D.A.; Ervin, C.S.; Jablonski, M.M. 2000: PEDF prevents Muller cell degeneration induced by RPE detachment. IOVS Investigative Ophthalmology and Visual Science 41(4): S850
Jablonski, M.M.; Tombran Tink, J.; Mrazek, D.A.; Ervin, C.S. 2000: PEDF protects photoreceptors from degeneration and induces opsin expression after RPE detachment. IOVS Investigative Ophthalmology and Visual Science 41(4): S332
Jadvar, H.; Connolly, L.P.; Treves, S.T.; Fischman, A.J. 1999: PEDIPET Diagnostic role of FDG PET in the evaluation of non-CNS pediatric tumors. Journal of Nuclear Medicine 40(5 Suppl): 203P
Zhu, C.; Graham, J. 2002: PEDMST, a new program for identity coefficients calculation and IBD patterns enumeration. American Journal of Human Genetics 71(4 Suppl): 570
Elbers, P.W.G.; Schwarte, L.A.; Ozekinci, H.; Ince, C. 2000: PEEP reduces intestinal Functional Capillary Density. Journal of Vascular Research 37(Suppl 1): 17
Wolfson, M.R.; Davidson, A.; Shaffer, T.H.; Roache, R.; Merwin, J.; Pucella, J. 1999: PEEP sensitivity during tidal liquid ventilation. Pediatric Research 45(4 Part 2): 326A
McNamee, C.; Noci, F.; Cronin, D.A.; Lyng, J.G.; Morgan, D.J.; Scannell, A.G.M. 2010: PEF based hurdle strategy to control Pichia fermentans, Listeria innocua and Escherichia coli k12 in orange juice. International Journal of Food Microbiology 138(1-2): 13-18
Jose, R.M.; Fischer, C.; Vlodov, J.; Iswara, K.; Tenner, S.M. 2002: PEG Intron A/Ribavirin is superior to Intron A/Ribavirin with and without Amantidine in the Treatment of Chronic Hepatitis C. Gastroenterology 122(4 Suppl 1): A-306
Greenwald, R.B. 2001: PEG drugs: an overview. Journal of Controlled Release: Official Journal of the Controlled Release Society 74(1-3): 159-171
Kamal, S.M.; Peter, T.; Rasenack, J.W. 2001: PEG interferon alpha-2a therapy enhances HCV specific CD4+ T helper 1 responses during and after treatment. Gastroenterology 120(5 Suppl 1): A 55
Gordon, F.D.; Morin, D.; Davis, C.; Goldberg, E.D.; Fabry, S.C.; Pomfret, E.A.; Pomposelli, J.J.; Lewis, W.D.; Jenkins, R.L.; Khettry, U. 2002: PEG interferon and ribavirin is effective and safe after liver transplantation. Hepatology 36(4 Part 2): 656A
Bordens, R.; Brassard, D.; Delorenzo, M.; Grace, M. 2001: PEG intron and interferon alfa-2b are comparable in regulating gene-expression for relevant anti-viral immuno-responsiveness. Journal of Leukocyte Biology Suppl: 36
Gugliotta, Luigi; Bulgarelli, Simona; Vianelli, Nicola; Russo, Domenico; Candoni, Anna; Michelutti, Teresa; Rupoli, Serena; Barulli, Sara; Latagliata, Roberto; Sacchi, Stefano; Martinelli, Vincenzo; Ciancia, Rosanna; Zumaglini, Federica; De Biasi, Ercole; Bucalossi, Alessandro; Mazzotta, Serena; Tabilio, Antonio 2003: PEG intron in essential thrombocythemia Two years treatment in 90 patients. Blood 102(11): 919a
Vetstovsek, S.; Lawhorn, K.; Giles, F.; Cortes, J.; Thomas, D.; Garcia Manero, G.; Ferrajoli, A.; Koller, C.; Beran, M.; Talpaz, M.; Freireich, E.J.; Kantarjian, 2003: PEG intron therapy for patients with myeloproliferative diseases Interim analysis of phase II Study. Blood 102(11): 919a
Bischoff, J.; Hesse, S.; Stemmler, H.J.; Zauner, S.; Gutschow, K. 2002: PEG liposomal doxorubicin combined with docetaxel A phase I trial in stage IV breast cancer. Breast Cancer Research and Treatment 76(Suppl 1): S133
Greenwald, R.B.; Grau, U.; Choe, Y.H.; Zhao, H. 2003: PEG pro-linkers Applications to biologically active molecules and proteins. Abstracts of Papers American Chemical Society 226(1-2): PMSE 377
Choe, Y.n, H.; Guan, Shuiyun; Greenwald, Richard, B. 2002: PEG prodrugs of 6-mercaptopurine -I Synthesis and in vitro studies. Proceedings of the American Association for Cancer Research 43: 419
Conover, C.D.; Borowski, V.; Mehlig, M.; Shum, K.L. 2002: PEG prodrugs of 6-mercaptopurine-II In vivo anti-cancer activity. Proceedings of the American Association for Cancer Research 43: 419
Pendri, A.; Martinez, A.; Guan, S.; Zhao, H.; Boro, M.; Greenwald, R.B. 1999: PEG prodrugs of amino containing anticancer agents-I Delivery based on 1,6-elimination. Proceedings of the American Association for Cancer Research 40: 583
Choe, Y.H.; Wu, D.; Guan, S.; Boro, M.; Wu, Z.; Lee, C.; Greenwald, R.B. 1999: PEG prodrugs of amino containing anticancer agents-II Delivery based on trimethyl-lock system. Proceedings of the American Association for Cancer Research 40: 583
Conover, C.D.; Guillen, V.; Hsu, J.; Yao, Z.; Shum, K.L. 1999: PEG prodrugs of amino containing anticancer agents-III In vivo solid tumor activity. Proceedings of the American Association for Cancer Research 40: 583
Choe, Y.n, H.; Wu, D.; Royzen, M.; Guan, S.; Greenwald, R.B. 2000: PEG prodrugs of cytosine arabinoside I Synthesis and in vitro studies. Proceedings of the American Association for Cancer Research 41: 523
Conover, C.D.; Borowski, V.; Hsu, J.; Shum, K.L. 2000: PEG prodrugs of cytosine arabinoside II In vivo anti-tumor activity. Proceedings of the American Association for Cancer Research 41: 523
Javaid, B.; O'toole, P.A. 2000: PEG replacement A simple and secure technique for combined bumper and wire retrieval. Gut 46(11): A65
Ideo, Gaetano; Antonucci, Giorgio; Attili, Adolfo F.; Babudieri, Sergio; Chirianni, Antonio; Craxi, Antonio; Di Perri, Giovanni; Francavilla, Antonio; Mangia, Alessandra; Picciotto, Antonino; Rizzetto, Mario; Ruggiero, Giuseppe; Suter, Fredy; Tripi, Salvatore; Sarracino, Massimo 2003: PEG-IFN alfa-2A plus amantadine. Hepatology 38(4 Suppl 1): 728A
Ideo, Gaetano; Attili, Adolfo; Chirianni, Antonio; Craxi, Antonio; Di Perri, Gianni; Picciotto, Antonino; Rizzetto, Mario; Ruggiero, Giuseppe; Suter, Fredy; Sarracino, Massimo 2002: PEG-IFN alfa-2a plus amantadine or ribavirin in naive patients with chronic hepatitis C. Hepatology 36(4 Part 2): 570A
Cariti, G.; Andreoni, M.; Calleri, G.; Manca, A.; Rosina, F.; Sartori, M.; Tabone, M.; Grasso, A.; Picciotto, A.; Smedile, A.; Rizzetto, M. 2002: PEG-IFN alfa-2a plus ribavirin vs IFN alfa-2a in naive patients with chronic hepatitis C and genotype 1. Hepatology 36(4 Part 2): 595A
Li, J.; Cubbedge, L.; Foster, K.; Gonsalez, T.; Lambiase, L. 2002: PEG-IFN and increase of weight based Ribavirin dosing are associated with increased risk of anemia. Journal of Hepatology 36(Suppl 1): 173
Flamm, S.L.; Cahan, J.; Goldman, J.; Nelligan, G.; Chua, D.; Shapiro, B.; Bawani, M.; Yapp, R.; Jurkovic, E.; Manka, D. 2002: PEG-Interferon alpha 2b 10 mcg/kg/wk+ribavirin vs PEG-Interferon alpha 2b 15 mcg/kg/wk+ribavirin Preliminary results from a prospective, randomized, controlled, multi-center trial. Hepatology 36(4 Part 2): 603A
Giles, F.; Kantarjian, H.; Waddelow, T.; O'brien, S.; Faderl, S.; Thomas, D.; Talpaz, M.; Cortes, J.; Estrov, Z. 2001: PEG-Intron is effective therapy for essential thrombocythemia. European Journal of Cancer 37(Suppl 6): S227
Buderus, S.; Emons, D.; Bindl, L.; Lentze, M.J. 2001: PEG-J tubes in children Successful longterm-option for enteral nutrition. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 350
E.T.yar, N.; Zhao, X.; Bentley, M.D. 2002: PEG-LHRH analog conjugates. Official Gazette of the United States Patent and Trademark Office Patents 1261(2)
Heller, J.; Ng, S.Y. 1999: PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers. Official Gazette of the United States Patent and Trademark Office Patents 1225(3)
Holowiecki, J.; Giebel, S.; Krawczyk, M.; Skotnicki, A.; Jakubas, B.; Dmoszynska, A.; Cioch, M.; Komarnicki, M.; Konopka, L.; Palynyczko, G.; Wozniczka, K. 2003: PEG-asparaginase as a part of induction therapy for adult acute lymphoblastic leukemia A phase II study by the Polish Adult Leukemia Group. Blood 102(11): 255b
Andruzzi, L.; Senaratne, W.; Hexemer, A.; Ober, C.K.; Kramer, E.J. 2003: PEG-based biostable surfaces by controlled radical polymerization. Abstracts of Papers American Chemical Society 225(1-2): PMSE 349
Torchilin, V.P. 2002: PEG-based micelles as carriers of contrast agents for different imaging modalities. Advanced Drug Delivery Reviews 54(2): 235-252
Belcheva, N.; Baldwin, S.P.; Fung, L.; Saltzman, W.M. 2000: PEG-based peptide and protein conjugates for specific interactions with PC12 cells. Journal of Controlled Release 64(1-3): 283-286
Boo, Y.C.; Lee, S.J.; Kim, W.S.; Lee, H.; Park, C.; Park, M.H.; Yoon, S.S.; Lee, M.H.; Park, C.H. 1999: PEG-conjugated ascorbate oxidase depletes plasma ascorbate for a prolonged period in mice. Free Radical Biology and Medicine 27(Suppl 1): S33
Zeuzem, S.; Hultcrantz, R.; Bourliere, M.; Goeser, T.; Marcellin, P.; Sanchez Tapias, J.; Harvey, J.; Brass, C.; Albrecht, J. 2003: PEG-interferon alfa-2b 15 mug/kg plus ribavirin 800-1400mg/day for 24 weeks in patients with HCV 2 or 3. Hepatology 38(5): 1326
Talpaz, M.; Cortes, J.; O'brien, S.; Wenske, C.; Rittweger, K.; Rakhit, A.; Hooftman, L.; Kantarjian, H. 2000: PEG-interferon alpha-2A with or without cytarabine in patients with relapsed or refractory chronic phase CML. Blood 96(11 Part 1): 736a-737a
Sulkowski, M.; Rothstein, K.D.; Stein, L.; Godofsky, E.; Shoultz, D.; Hudnall, R.; Huff, M.; Dieterich, D. 2001: PEG-interferon alpha2B plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alpha or interferon alpha-2B plus ribavirin therapy. Hepatology 34(4 Pt 2): 419A
Wirth, S.; Kullmer, U.; Lang, T.; Pieper Boustani, H.; Wintermeyer, P.; Gerner, P. 2003: PEG-interferon-alpha-2b and ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 38(4 Suppl 1): 737A
Glue, P.; Fang, J.; Sabo, R.; Rouzier Panis, R.; Raffanel, C.; France, N.; Gupta, S.K.; Jacobs, S.; Garaud, J.J.; Albrecht, J.K. 1999: PEG-interferon-alpha2B Pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Hepatology 30(4 Part 2): 189A
Mcgarrity, T.J.; Peiffer, L.P.; Rhoades, K.; Chen, S.T.; Friedrich, R.; Mcdonald, T.J.; Rosenberg, D.; Bross, R.J.; Smith, M.A.; Pickle, H.I. 2003: PEG-intron plus ribavirin in chronic hepatitis C patients refractory to prior treatment End of follow-up report. American Journal of Gastroenterology 98(9 Suppl): S88
Nablo, B.; Armstrong, N.R.; Saavedra, S.S. 1999: PEG-modification of insoluble dyes and Heme-proteins to allow for solution electrochemical characterization and increased sol-gel compatibility. Abstracts of Papers American Chemical Society 217(1-2): ANYL 57
Malik, F.; Brew, J.; Maidment, S.A.; Delgado, C.; Francis, G.E. 2000: PEG-modified erythropoietin with improved efficacy. Experimental Hematology 28(7 Suppl 1): 106
Malik, F.; Hussain, N.; Maidment, S.; Delgado, C.; Brown, K.E.; Robertson, C.D.; Tomlin, L.; Nicolson, M.; Francis, G.E. 2001: PEG-modified interferon-alpha with well conserved bioactivity. Experimental Hematology 29(8 Suppl 1): 45
Oyama, K.; Suzuki, T.; Katou, Y.; Yoshioka, S.; Takeuchi, T.; Irei, M.; Koike, M.; Takahashi, M. 2003: PEG-rHuMGDF prevent myelosuppression and improved survival in mice. Blood 102(11): 175b
Williams, L.D.; Hershfield, M.S.; Kelly, S.J.; Saifer, M.G.P.; Sherman, M.R. 2003: PEG-urate oxidase conjugates and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)
Dalke, D.D.; Donovan, J.; Goff, J.; Monsour, H.; Box, T.; Triebling, A.; Brouillette, D.; Levine, R.; Kim, L.; Malliard, M. 2001: PEG12000-IFN alfa 2b 05 mcg/kg+ribavirin 800 mg/day vs PEG12000-IFN alfa 2b 15 mcg/kg+ribavirin 800 mg/day for 48 weeks for treatment of patients with hepatitis C who failed or relapsed after treatment with combination therapy Interim results. Hepatology 34(4 Pt 2): 335A
ChenRongYi; FanYiMing; TuYaTing; ChenHongXiang; ShenQin; XuLi 2010: PEGFC1-IGFBP7 induces apoptosis of malignant melanoma cell line SK-MEL-28. Chinese Journal Of Cancer Biotherapy: 1, 36-39
Finch, H.; Stoy, N. 2002: PEGs in chronic neurological disorders. Clinical Medicine 2(4): 378
Chapman, A.P. 2002: PEGylated antibodies and antibody fragments for improved therapy: a review. Advanced Drug Delivery Reviews 54(4): 531-545
Chekhonin, V.P.; Zhirkov, Y.A.; Gurina, O.I.; Ryabukhin, I.A.; Lebedev, S.V.; Kashparov, I.A.; Blinov, D.V.; Dmitrieva, T.B. 2003: PEGylated immunoliposomes specific to astrocytes. Doklady Akademii Nauk 391(6): 832-835
Otsuka, H.; Nagasaki, Y.; Kataoka, K. 2003: PEGylated nanoparticles for biological and pharmaceutical applications. Advanced Drug Delivery Reviews 55(3): 403-419
Wang, J.L.; Qian, X.; Chinookoswong, N.; Lu, J.; Chow, G.; Theill, L.; Shi, Z.Q. 2001: PEGylated soluble TNF receptor-1 reduces insulitis and incidence of spontaneous and cyclophosphamide induced diabetes in NOD mice. Diabetes 50(Suppl 2): A266
Esposito, P.; Barbero, L.; Caccia, P.; Caliceti, P.; D'antonio, M.; Piquet, G.; Veronese, F.M. 2003: PEGylation of growth hormone-releasing hormone analogues. Advanced Drug Delivery Reviews 55(10): 1279-1291, 26 September
Davidson, T.J.; Gallant, R.K. 2000: PEI mussel aquaculture Changing technologies. Journal of Shellfish Research 19(1): 652
Shiina, S.; Teratani, T.; Obi, S.; Sato, S.; Koike, Y.; Dan, Y.; Taniguchi, H.; Akamatsu, M.; Kato, N.; Yoshida, H.; Imamura, M.; Hamamura, K. 1999: PEIT alone vs combination of PEIT and PMCT in the treatment of hepatocellular carcinoma A prospective randomized trial. Gastroenterology 116(4 Part 2): A1275
D.B.ult, L.E.; Collier, M.A.; Fitzsimmons, R.J. 2002: PEMF signals suppress growth of human chondrosarcoma cells in vitro. Laboratory Investigation 82(1): 12A-13A
Tepper, J.C.; Kuo, P.; Mcdermott, K.L. 2002: PEMF stimulator for treating osteoporosis and stimulating tissue growth. Official Gazette of the United States Patent and Trademark Office Patents 1260(2)
Stanton, J.B.; Schultz Cherry, S.; Larsen, D.; Kelley, L.; Brown, C.C. 2002: PEMS-associated astrovirus infection in adult turkeys. Poultry Science 81(Suppl 1): 160
Qureshi, M.A.; Heggen Peay, C.L.; Schat, K.A.; Sherry, B.; Cheema, M.A.; Ali, R.A.; O'connell, P.H. 2001: PEMS-associated reovirus Viral replication, effects on avian cell liviability, and cytokine expression. Journal of Dairy Science 84(Suppl 1): 130-131
Zhu, X.; Song, J.; Mar, M.H.; Craciunescu, C.; Zeisel, S. 2003: PEMT -/- mice have increased stem cell proliferation in hippocampal neuroepithelium on embryonic day 17. FASEB Journal 17(4-5): Abstract 709
Marengo, B.; Cecchini, F.; La Porta, C.; Tessitore, L. 2003: PEMT inactivation A novel marker for initiated hepatocytes?. International Journal of Molecular Medicine 12(Suppl 1): S64
Zhu, X.; Mar, M.H.ng H.; Song, J.; Zeisel, S.H. 2002: PEMT knockout mice become choline deficient despite normal dietary choline intake. FASEB Journal 16(4): A222
Medico, E.; Marengo, B.; Casazza, A.; Pastor, A.; Bosco, M.; Comoglio, P.M.; Tessitore, L. 2000: PEMT2 expression, growth arrest and apoptosis in MLP 29 cells. International Journal of Biological Markers 15(3): 249
Mariani, E.; Neri, S.; Meneghetti, A.; Cattini, L.; Facchini, A. 2000: PEN5 expression is preserved on NK cells from subjects over seventy years old. Tissue Antigens 55(Suppl 1): 79-80
Rao, S.K.; Reiskind, J.B.; Bowes, G. 1999: PEPC with CAM properties from C4-type Hydrilla. Plant Biology (Rockville) : 169
Tubert, F.B.; Abril, A.V. 2000: PEPCK-insulin gene construct and transgenic mouse. Official Gazette of the United States Patent and Trademark Office Patents 1239(4)
Beiko, D.T.; Watterson, J.D.; Knudsen, B.E.; Bennett, J.D.; Pace, K.T.; Honey, R.J.hn D'a; Denstedt, J.D. 2003: PERC MentorTM A new computer-based virtual reality simulator for percutaneous renal access. Journal of Urology 169(4 Suppl): 473
Bout, B. 2003: PERC6TM as production platform for human monoclonal antibodies. Human Antibodies 12(1-2): 30
Gerlai, R.; Adams, B.; Fitch, T.; Chaney, S.; Baez, M. 2002: Performance deficits of mGluR8 knockout mice in learning tasks: the effects of null mutation and the background genotype. Neuropharmacology 43(2): 235-249
Zimmermann, J.; Reischig, T.; Fischer, J.; Soehler, S.; Stengl, M. 2002: PERIOD appears to be a circadian clock component in the cockroach Leucophaea maderae. Zoology (Jena) 105(Suppl 5): 90
Sato, S.; Chuman, Y.; Matsushima, A.; Shimohigashi, Y.; Tominaga, Y.; Shimohigashi, M. 2001: PERIOD clock protein of the last summer cicada Meimuna opalifera cDNA cloning and structural analysis. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 130A(4): 874-875
Ron, D.; Harding, H.P. 2000: PERK and translational control by stress in the endoplasmic reticulum. Sonenberg, Nahum Author, Hershey, John W B Author, Mathews, Michael B Author Cold Spring Harbor Monograph Series; Translation control of gene expression 547-560
Suen, K.C.; Yu, M.S.; Hugon, J.; So, K.F.; Chang, R.C.C. 2003: PERK might not be involved in beta-amyloid peptide-induced endoplasmic reticulum stress in neurons. Journal of Neurochemistry 87(Suppl 1): 96
Silva, N.F.; Goring, D.R. 2001: PERK1, a novel receptor-like protein kinase, is rapidly induced in response to wounding. Plant Biology (Rockville) : 33-34
Patience, C.; Quinn, G.; Wood, J.; Ryan, D.; Suling, K.; Moran, K.; Kolber Simmons, D.; Schuurman, H.J.; Hawley, R. 2003: PERV transmission characteristics of galactosyl-transferase knockout pig cells. Xenotransplantation 10(5): 490
Denner, J.; Specke, V.; Tacke, S.; Schwendemann, J.; Coulibaly, C.; Plesker, R.; Kurth, R.; Langford, G.; Schuuman, H.J. 2001: PERVs Diagnostics, adaptation to human cells, but no transmission to small animals, non-human primates and man. Xenotransplantation 8(Suppl 1): 126-127
Panemangalore, M.; Bebe, F.N. 2004: Pesticides influence concentrations of trace metals zinc and copper in tissues of rats. FASEB Journal 18(4-5): Abstract 364
Chin, B.B.; Nakamoto, Y.; Kraitchman, D.L.; Marshall, L.; Wahl, R. 2002: PET CT evaluation of 18FDG myocardial uptake Effect of respiratory motion. Journal of Nuclear Medicine 43(5 Suppl): 190P
Moody, R.; Shulkin, B.; Yanik, G.; Hutchinson, R.; Castle, V. 2001: PET FDG imaging in pediatric lymphomas. Journal of Nuclear Medicine 42(5 Suppl): 39P
Dimitrakopoulou Strauss, A.; Strauss, L.G.; Schwarzbach, M.; Burger, C.; Irngartinger, G.; Lehnert, T. 2001: PET FDG in soft tissue sarcomas. Journal of Nuclear Medicine 42(5 Suppl): 306P-307P
Mueller, S.P.; Nelles, G.; Spiekermann, G.; Jueptner, M.; Leonhardt, G.; Bockisch, A. 2000: PET activation studies of early functional reorganization before motor recovery from stroke. Journal of Nuclear Medicine 41(5 Suppl): 140P
Yusuke, K.; Yoshikubo, S.I.; Ejima, N.; Takeda, M.; Kobayashi, M.; Watanabe, Y.; Sawada, T. 2000: PET activation study on a conscious monkey performing visual operant tasks. Neuroscience Research Suppl (24): S146
Carhuapoma, J.Ricardo. 2003: PET after cardiac arrest: does it have any role in resuscitation medicine research?. Journal of the Neurological Sciences 210(1-2): 1-2
Jagust, W.J.; Eberling, J.L.; Mungas, D.M.; Wu, C.C.; Petkov, C.I.; Finkbeiner, A.M.; Buonocore, M.; Brunberg, J.; Haan, M.N. 2000: PET and MRI in a community sample with cognitive impairment The SALSA study. Neurology 54(7 Supp 3): A77
Delbeke, D.; Martin, W.H. 2004: PET and PET-CT for evaluation of colorectal carcinoma. Seminars in Nuclear Medicine 34(3): 209-223
Jayson, G.C.; Zweit, J.; Mulatero, C.; Hastings, D.; Julyan, P.; Ranson, M.; Lawrance, J.; Mcgown, A.; Jackson, A.; Hakannson, L.; Groenwegen, G.; Lehmann, F.; Wagstaff, J.; Levitt, D.; Tang, T.; Zwierzina, H. 2001: PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833 An EORTC-biological treatment development group phase I study. Proceedings of the American Association for Cancer Research 42: 832-833
Lubberink, M.; Widstrom, C.; Tolmachev, V.; Westlin, J.E.; Lundqvist, H. 1999: PET and SPECT for indium-octreotide based diagnostics and nuclide therapy dosimetry. Journal of Nuclear Medicine 40(5 Suppl): 220P
Grosu, A.L.; Weber, W.; Feldmann, H.J. 2000: PET and SPECT in three-dimensional treatment planning of brain gliomas. Feldmann, H Journal Author, Kneschaurek, P Author, Molls, M Author Frontiers of Radiation Therapy and Oncology Three-dimensional radiation treatment: Technological innovations and clinical results 97-105
Kalifa, J.E.; Jin, Y.P.; Laine, A.F.; Esser, P.D. 2000: PET and SPECT reconstruction with non-linear thresholding estimators. Journal of Nuclear Medicine 41(5 Suppl): 132P
Brooks, D.J. 2000: PET and SPECT studies of neuropharmacology in PD. European Journal of Neurology 7(Suppl 3): 177
Small, G.W.; Ercoli, L.M.; Huang, S.C.; Komo, S.; Bookheimer, S.Y.; Saxena, S.; Silverman, D.H.; Mega, M.S.; Mazziotta, J.C.; Wu, H.M.; Cummings, J.L.; Phelps, M.E. 1999: PET and genetic risk for Alzheimer disease. Journal of Nuclear Medicine 40(5 Suppl): 70P
Wu, J.C.; Inubushi, M.; Sundaresan, G.; Barrio, J.R.; Satyamurthy, N.; Namavari, M.; Schelbert, H.; Gambhir, S.S. 2002: PET and optical imaging of cardiac reporter gene expression in living rats. Journal of Nuclear Medicine 43(5 Suppl): 1P
Brownell, A.L.; Van Nguyen, T.; Chen, C.Y.J.; Livni, E.; Cavagna, F.; Rosen, B.R.; Isacson, O.; Jenkins, B.G. 1999: PET and phMRI studies of dopamine receptor modulation in PD models. Society for Neuroscience Abstracts 25(1-2): 434
Nitzsche, E.U.; Walter, M.A.; Schirp, U.; Tyndall, A.; Mueller, J. 2003: PET as an aid to diagnose and monitor giant cell arteritis Feasibility and first clinical results. Journal of Nuclear Medicine 44(5 Suppl): 45P-46P
Merlet, P.; Frouin, F.; Rande, J.L.D.bois; Syrota, A. 2001: PET assessment of coronary flow reserve helps identify physiologic cardiac hypertrophy. Journal of Nuclear Medicine 42(5 Suppl): 91P
Duvernoy, C.; Rattenhuber, J.; Seifert Klauss, V.; Bengel, F.; Meyer, C.; Schwaiger, M. 1999: PET assessment of myocardial blood flow before and after hormone replacement therapy in postmenopausal women. Journal of the American College of Cardiology 33(2 Suppl A): 303A
Campisi, R.; Nathan, L.; Pampaloni, M.H.; Schoder, H.; Sayre, J.W.; Chaudhuri, G.; Schelbert, H.R. 2000: PET based measurements of myocardial blood flow for evaluating coronary microcirculatory function after menopause and effects of long-term hormone replacement therapy. Journal of Nuclear Medicine 41(5 Suppl): 4P
Adam, L.E.; Karp, J.S.; Smith, R.J. 1999: PET camera performance measurements A comparison between three PET cameras. Journal of Nuclear Medicine 40(5 Suppl): 76P
Klein, G.J.; Jamsheed, H.C.; Reutter, B.W.; Saloner, D.A.; Schreck, C.E.; Botvinick, E.H.; Budinger, T.F.; Huesman, R.H. 2001: PET cardiac contractile motion compensation via tagged MRI priors. Journal of Nuclear Medicine 42(5 Suppl): 8P
Hattori, N.; Huang, S.C.; Wu, H.M.; Liao, W.H.; O'phelan, K.; Glenn, T.C.; Vespa, P.M.; Phelps, M.E.; Hovda, D.A.; Bergsneider, M. 2002: PET characterization of glucose metabolism in patients with diffuse versus focal brain injury. Journal of Nuclear Medicine 43(5 Suppl): 247P
Kumar, A.; Mann, S.; Sossi, V.; Ruth, T.J.; Stoessl, A.J.; Ahn, S.; Schulzer, M.; Lee, C.S. 2003: PET correlates of the short duration response to levodopa Comparisons between the two sides in asymmetric Parkinsons disease. Neurology 60(5 Suppl 1): A295
Strauss, L.G.; Dimitrakopoulou Strauss, A.; Kontaxakis, G.; Burger, C.; Mikolajczyk, K. 1999: PET data processing and image evaluation on PC systems. Journal of Nuclear Medicine 40(5 Suppl): 292P
Zober, T.G.; Brown, R.P.; Sandberg, K.; Hilton, J.; Bluemke, D.A.; Sy, M.A.; Rauseo, P.; Mathews, W.B.; Ravert, H.T.; Dannals, R.F.; Szabo, Z. 2003: PET demonstrates upregulation of the renal angiotensin-II receptors in experimental renovascular hypertension. Journal of Nuclear Medicine 44(5 Suppl): 142P
Pampaloni, M.H.; Hsueh, W.A.; Quinones, M.; Sayre, J.S.; Schelbert, H.R. 2000: PET determined myocardial blood flow demonstrates abnormal coronary vasomotion in insulin resistance without diabetes. Journal of Nuclear Medicine 41(5 Suppl): 44P
Gutierrez Abad, D.; Gonzalez Larriba, J.L.; Lopez Garcia Asenjo, J.A.; Camara Vicario, J.C.; Alfonso San Segundo, R.; Diaz Rubio, E. 2002: PET diagnosis of an isolated relapse in a patient with a previously resected stage I epidermoid carcinoma of the lung. Oncologia 25(6): 59-63
Lewis, M.R.; Laforest, R.; Cutler, P.D.; Axworthy, D.B.; Mallett, R.W.; Fritzberg, A.R.; Anderson, C.J. 2000: PET dosimetry of 64Cu in a nonhuman primate Pretargeted versus conventional radioimmunotherapy. Journal of Nuclear Medicine 41(5 Suppl): 238P
Gobbo, C.L.; Moresco, R.M.; Antonini, A.; Carpinelli, A.; Lucignani, G.; De Notaris, R.; Barone, P.; Panzacchi, A.; Pezzoli, G.; Fazio, F. 2001: PET evaluation of dopamine transporters in early and late onset patients with Parkinsons disease. Journal of Nuclear Medicine 42(5 Suppl): 226P
Esposito, G.; Yokoi, F.; Stephane, M.; Nestadt, G.; Dogan, S.; Szabo, Z.; Gjedde, A.; Wong, D.F. 2000: PET evaluation of pre and post synaptic serotonin function in schizophrenia using statistical parametric mapping analysis. Journal of Nuclear Medicine 41(5 Suppl): 205P-206P
Carson, R.E.; Lang, L.; Wu, Y.; Ma, Y.; Der, M.G.; Herscovitch, P.; Eckelman, W.C. 2001: PET evaluation of two 18F-labeled 5-HT1A antagonists with intermediate affinity. Journal of Nuclear Medicine 42(5 Suppl): 106P
Lee, J.S.; Lee, D.S.; Kang, E.; Oh, S.H.; Kim, J.W.; Koo, J.W.; Kim, C.S.; Park, K.S.; Chung, J.K.; Lee, M.C. 2001: PET evidence of cross-modal plasticity in auditory cortex of postlingual deafness. Journal of Nuclear Medicine 42(5 Suppl): 147P
Halldin, C.; Sandell, J.; Chou, Y.H.; Hall, H.; Thorberg, S.O.; Werner, T.; Swahn, C.G.; Farde, L. 1999: PET examination of NAD-299, a new radioligand for visualization of the 5-HT1A receptor. Journal of Nuclear Medicine 40(5 Suppl): 38P
Talvik, M.; Nordstrom, A.L.; Olsson, H.; Halldin, C.; Farde, L. 2003: PET examinations or thalamic D2 receptors in schizophrenic patients. European Neuropsychopharmacology 13(Suppl 4): S330
Artal, R.; Waxman, A.D.; Williams, C.M.; Tcherniantchouk, O.; D'agnolo, A.; Mohsenifar, Z.; Morales, J.A.; Fuller, C.; Mckenna, R. 2002: PET fluorodeoxyglucose imaging in defining a strategy for mediastinoscopy. Journal of Nuclear Medicine 43(5 Suppl): 303P
Inoue, T. 1999: PET for cancer patients. Radioisotopes 48(12): 745-751
Becherer, A.; Goessweiner, S.; Diemling, M.; Jank, J.; Poetzi, C.; Schmaljohann, J.; Dudczak, R.; Kletter, K. 1999: PET for differentiation of viable tumor from osteoradionecrosis in head and neck cancer. Journal of Nuclear Medicine 40(5 Suppl): 236P
Kotzerke, J.ör.; Gschwend, J.ür.E.; Neumaier, B. 2002: PET for prostate cancer imaging: still a quandary or the ultimate solution?. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(2): 200-202
Takamatsu, H.; Noda, A.; Ichise, R.; Tatsumi, M.; Nishimura, S. 2002: PET images following treatment with an anxiety-evoking agent, mCPP in conscious rhesus monkeys. Japanese Journal of Pharmacology 88(Suppl 1): 237P
Drevets, W.C. 2000: PET imaging correlates of depression and mania. Journal of Psychopharmacology 14(3 Suppl): A1
Pillai, V.; Ma, Y.; Dhawan, V.; Greene, P.; Fahn, S.; Breeze, R.; Freed, C.; Eidelberg, D. 2002: PET imaging in Parkinsons disease four years following embryonic dopamine cell transplantation. Neurology 58(7 Suppl 3): A241-A242
Sobesky, J. 2003: PET imaging in cerebral ischemia. European Journal of Neurology 10(Suppl 1): 213
Rajendran, J.G.; Peterson, L.M.; Schwartz, D.S.; Scharnhorst, J.D.; Koh, W.J.; Eary, J.F.; Krohn, K.A. 2002: PET imaging in head and neck cancer with 18FMISO and 18FDG Evaluating different aspects of tumor biology - hypoxia and metabolism. Proceedings of the American Association for Cancer Research 43: 758
Bar-Shalom, R.; Valdivia, A.Y.; Blaufox, M.D. 2000: PET imaging in oncology. Seminars in Nuclear Medicine 30(3): 150-185
Jones, H.A.; Donovan, T.; Goddard, M.J.; Mcneil, K.; Atkinson, C.; Clark, J.C.; White, J.F.; Chilvers, E.R. 2003: PET imaging of -FDG as a non-invasive indicator of infection versus rejection in lung transplant recipients. Journal of Heart and Lung Transplantation 22(1S): S192
Meyer, M.A.; Potter, N.T.; Aberzanak, N. 2001: PET imaging of 18F-FDG brain uptake in PCR confirmed cases of dentatorubropallidoluysian atrophy. Journal of Nuclear Medicine 42(5 Suppl): 227P
Conti, P.S.; Bading, J.R.; Mouton, P.; Links, J.M.; Alauddin, M.M.; Wong, D.F.; Ravert, H.T.; Hilton, J.; Anderson, J.H. 2001: PET imaging of 2-fluoro-5-11C-methyl-1-beta-D-arabinofuranosyluracil indicates brain tumor growth rate in dogs. Journal of Nuclear Medicine 42(5 Suppl): 83P
Toczek, M.T.; Spanaki, M.V.; Lang, L.; Carson, R.E.; Der, M.G.; Fazilat, S.; Herscovitch, P.; Eckelman, W.C.; Theodore, W.H. 2001: PET imaging of 5HT1A receptors in temporal lobe epilepsy. Neurology 56(8 Suppl 3): A390
Martinez, D.; Broft, A.; Foltin, R.; Perez, A.; Hwang, D.R.; Huang, Y.; Mawlawi, O.; Cutler, B.; Peters, C.; Van Heertum, R.L.; Fischman, M.W.; Laruelle, M. 2002: PET imaging of D2 receptors in striatal substructures and the positive effects of cocaine in chronic cocaine abusers. Journal of Nuclear Medicine 43(5 Suppl): 107P-108P
Yaghoubi, S.S.; Goldman, R.; Barrio, J.R.; Namavari, M.; Iyer, M.; Satyamurthy, N.; Herschman, H.R.; Phelps, M.E.; Gambhir, S.S. 2000: PET imaging of FHBG in humans A tracer for monitoring Herpes Simplex Virus Type 1 thymidine kinase suicide gene therapy. Journal of Nuclear Medicine 41(5 Suppl): 73P-74P
Jacobs, A.H.; Winkeler, A.; Dittmar, C.; Hartung, M.; Garlip, G.; Kummer, C.; Vollmar, S.; Graf, R.; Wienhard, K.; Heiss, W.D. 2002: PET imaging of HSV-1 amplicon vector-mediated gene expression. Journal of Neurovirology 8(Suppl 1): 110
Baldwin, Ronald M.; Chaly, Thomas; Tamagnan, Gilles; Staley, J.K.; Al Tikriti, M.S.; Hou, Y K.; Gu, Xiao Hui; Zong, R.; Baldessarini, Ross J.; Neumeyer, John L.; Garg, P. 2003: PET imaging of N- fluoropropyl-2B-carbomethoxy-3B-. Abstracts of Papers American Chemical Society 225(1-2): NUCL 137
Ponomarev, V.; Lyddane, C.; Doubrovin, M.; Balatoni, J.; Finn, R.; Blasberg, R.; Sadelain, M.; Tjuvajev, J.G. 2001: PET imaging of TCR-dependent NFAT-mediated activation of T-lymphocytes. Journal of Nuclear Medicine 42(5 Suppl): 277P-278P
Watanabe, Y.; Takahashi, K.; Doi, H.; Kato, K.; Watanabe, Y.; Hosoya, T.; Engler, H.; Langstrom, B.; Noyori, R.; Suzuki, M. 2003: PET imaging of a CNS-type prostacyclin receptor in human brain. Neuroscience Research Suppl (26): S53
Martinez, D.; Hwang, D.R.; Broft, A.; Mawlawi, O.; Simpson, N.; Ngo, K.; Pidcock, J.; Van Heertum, R.; Laruelle, M. 2000: PET imaging of amphetamine-induced endogenous dopamine release in mesolimbic and nigro-striatal dopamine systems in humans. Journal of Nuclear Medicine 41(5 Suppl): 105P
Grunder, G.M.; Siessmeier, T.; Piel, M.; Schirrmacher, R.; Lange Asschenfeldt, C.; Vernaleken, I.; Buchholz, H.G.; Stoeter, P.; Drzezga, A.; Luddens, H.; Bartenstein, P.; Roesch, F. 2000: PET imaging of benzodiazepine receptors in the human brain Evaluation of fluoroethylflumazenil. Journal of Nuclear Medicine 41(5 Suppl): 199P
Van Waarde, A.; Vaalburg, W.; Doze, P.; Bosker, F.J.; Elsinga, P.H. 2004: PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?. Current Pharmaceutical Design 10(13): 1519-1536
Bencherif, B.; Endres, C.J.; Musachio, J.L.; Villalobos, A.; Hilton, J.; Scheffel, U.; Dannals, R.F.; Williams, S.; Frost, J.J. 2002: PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor. Synapse 45(1): 1-9
Murphy, K.; Isaev, G.; Guz, A.; Adams, L. 2000: PET imaging of cerebral areas concerned with ventilatory load compensation in awake man. FASEB Journal 14(4): A645
Wong, D.F. 1999: PET imaging of dopamine receptors and transporters in neuropsychiatric disorders and pharmacological studies. Japanese Journal of Pharmacology 79(Suppl 1): 27P
Watanabe, Y.; Kuratsune, H.; Yamaguti, K.; Lindh, G.; Evengard, B.; Matsumura, K.; Onoe, H.; Hagberg, G.; Langstrom, B. 1999: PET imaging of fatigue state in the brains of chronic fatigue syndrome patients. Society for Neuroscience Abstracts 25(1-2): 1800
Ponomarev, V.; Dubrovin, M.; Balatoni, J.; Finn, R.; Blasberg, R.G.; Tjuvajev, J.G. 2000: PET imaging of p53 gene expression in tumors. Journal of Nuclear Medicine 41(5 Suppl): 263P-264P
Pirtskhalaishvili, G.; Mathis, C.; Arlotti, J.A.; Pflug, B.R.; Nelson, J.B. 2002: PET imaging of prostate cancer through manipulation of fatty acid synthase. Journal of Urology 167(4 Suppl): 362
Mann, J.J.; Oquendo, M.A.; Parsey, R.V.; Campbell, C.; Keilp, J.; Cooper, T.B.; Malone, K.M.; Kegeles, L.S.; Slifstein, M.; Van Heertum, R. 2000: PET imaging of serotonin responsivity in bipolar and unipolar mood disorders. Journal of Nuclear Medicine 41(5 Suppl): 200P
Price, J.C.; Kelley, D.E.; Ryan, C.M.; Meltzer, C.C.; Drevets, W.C.; Mathis, C.A.; Mazumdar, S.; Reynolds, C.F.IIi 2001: PET imaging of serotonin-1A receptors in type 2 diabetes Evidence of increased binding. Journal of Nuclear Medicine 42(5 Suppl): 18P
Barrio, J.R.; Huang, S.C.; Cole, G.M.; Satyamurthy, N.M.; Petric, A.; Phelps, M.E.; Small, G.W. 1999: PET imaging of tangles and plaques in Alzheimer disease. Journal of Nuclear Medicine 40(5 Suppl): 70P-71P
Barrio, J.R.; Huang, S.C.; Cole, G.; Satyamurthy, N.; Petric, A.; Phelps, M.E.; Small, G. 1999: PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. Journal of Labelled Compounds and Radiopharmaceuticals 42(Suppl 1): S194-S195
Madras, B.K.; Babich, J.W.; Livni, E.; Bonab, A.A.; Fischman, A.J. 2000: PET imaging of the dopamine transporter A window on dopamine neuron regeneration in Parkinsonian monkeys. Journal of Nuclear Medicine 41(5 Suppl): 104P
Madras, B.K.; Bonab, A.A.; Livni, E.; Fischman, A.J. 2002: PET imaging of the dopamine transporter Evidence for compensatory DAT down-regulation with sustained improvement in activity of Parkinsonian monkey. Journal of Nuclear Medicine 43(5 Suppl): 233P
Frost, J.J. 2001: PET imaging of the opioid receptor: the early years. Nuclear Medicine and Biology 28(5): 509-513
Buck, A.; Turi Nagy, E.; Weber, B.; Henke, K. 1999: PET imaging of unconscious perception and retrieval. Journal of Nuclear Medicine 40(5 Suppl): 261P
Perlman, S.B.; Woodard, A.R.; Griffith, R.; Seidenberg, M.; Hermann, B.P.; De La Pena, R.C.; Hanson, J.M.; Pyzalski, R.W.; Rutecki, P.; Jones, J.C. 1999: PET imaging predicts postoperative decline in verbal memory in patients with partial complex epilepsy. Journal of Nuclear Medicine 40(5 Suppl): 266P-267P
Dhawan, V.; Ma, Y.; Fukuda, M.; Breeze, R.; Greene, P.; Fahn, S.; Freed, C.; Eidelberg, D. 2001: PET imaging two years following embryonic dopamine cell transplantation for Parkinsons disease. Neurology 56(8 Suppl 3): A270-A271
Feng, Q.; Holtz, D.; Shiue, C.Y.; Shiue, G.G.; Rubin, S.C.; Coukos, G.; Zhuang, H.M.; Alavi, A. 2003: PET imaging with 18F-Squalamine of a mouse model of ovarian carcinoma overexpressing VEGF-164. Journal of Nuclear Medicine 44(5 Suppl): 296P
Rajendran, J.G.; Meyer, J.; Schwartz, D.L.; Kinahan, P.E.; Cheng, P.M.; Hummell, S.M.; Phillips, M.; Krohn, K.A. 2003: PET imaging with FMISO permits hypoxia directed radiotherapy dose escalation in head and neck cancer. Journal of Nuclear Medicine 44(5 Suppl): 127P-128P
Buchholz, H.G.; Herzog, H.; Helisch, A.; Reber, H.; Nickel, O.; Bartenstein, P. 2003: PET imaging with yttrium-86 Improvement of quantitation by background subtraction. Journal of Nuclear Medicine 44(5 Suppl): 261P
Minn, H. 2000: PET in assessment of radiation effects. Radiotherapy and Oncology 56(Suppl 1): S119
Suhara, T. 1999: PET in neuropsychiatric drug pharmacokinetics. Japanese Journal of Pharmacology 79(Suppl 1): 27P
Orlefors, H.; Sundin, A.; Bergstrom, M.; Oberg, K.; Eriksson, B. 1999: PET in the management of patients with neuroendocrine tumors. European Journal of Clinical Investigation 29(Suppl 1): 29
Hershey, T.; Moerlein, S.M.; Perlmutter, J.S. 2001: PET investigations of Parkinsons disease. Chesselet, Marie-Francoise Contemporary Clinical Neuroscience Molecular mechanisms of neurodegenerative diseases 177-193
Kim, Y.K.; Bencherif, B.; Wand, G.S.; Mccaul, M.E.; Dannals, R.F.; Frost, J.J. 2003: PET measurement of mu- and delta-opioid receptor availability before and after naltrexone treatment in alcohol dependence. Journal of Nuclear Medicine 44(5 Suppl): 65P-66P
Montgomery, A.J.; Mctavish, S.F.B.; Cowen, P.J.; Grasby, P.M. 2003: PET measurement of the effect of dietary tyrosine depletion on raclopride binding An raclopride PET study. Clinical Science (London) 104(Suppl 49): 36P
Mesotten, L.V.; Zietkiewicz, M.; Dispersyn, G.D.; Maes, A.; Perek, B.; Nuyts, J.; Bormans, G.; De Groot, T.; Borgers, M.; Flameng, W.; Mortelmans, L. 1999: PET measurements of flow and metabolism in an experimental model of patchy necrosis. Journal of Nuclear Medicine 40(5 Suppl): 5P
Feigin, A.; Ma, Y.; Zgaljardic, D.; Carbon, M.; Dhawan, V.; Eidelberg, D. 2003: PET measures of longitudinal progression in presymptomatic Huntingtons disease. Neurology 60(5 Suppl 1): A246
Drevets, W.C.; Frank, E.; Price, J.C.; Kupfer, D.J.; Holt, D.; Greer, P.; Huang, H.; Gautier, C.; Mathis, C.A. 1999: PET measures of serotonin 1A receptor binding potential in major depression. Society for Neuroscience Abstracts 25(1-2): 1799
Prevost, S.; Boucher, L.; Croteau, E.; Rijo, J.; Benard, F. 2003: PET metabolic activity measurements as independent predictors of mortality in non small cell lung cancer. Journal of Nuclear Medicine 44(5 Suppl): 173P
Morris, E.D.; Wang, C.; Muzic, R.F. 2003: PET modeling techniques to replace microdialysis in small animals Can endogenous neurotransmitter changes be measured continuously?. Journal of Nuclear Medicine 44(5 Suppl): 115P
Singh, Tajinder P.; Di Carli, Marcelo F. 2000: PET myocardial perfusion imaging Role in clinical decision-making in children with suspected coronary abnormalities. Circulation 102(18): 2; 772
Merhige, M.E.; Houston, T.; Shelton, V.; Kay, J.; Stern, G.; Oliverio, J.; Fast, E.; Shanahan, J.; D'arcy, B.; Saki, D.; Breen, W., J.; Rueda, B. 1999: PET myocardial perfusion imaging reduces the cost of coronary disease management by eliminating unnecessary invasive diagnostic and therapeutic procedures. Circulation 100(18): I26-I27
Chugani, H.T. 2002: PET of localization of epileptogenic lesions in children. Developmental Neuroscience 24(5): 451
Ginovart, N.; Wilson, A.A.; Meyer, J.H.; Hussey, D.; Houle, S. 2001: PET quantification of 11C-DASB binding to the serotonin transporter in human. Journal of Nuclear Medicine 42(5 Suppl): 105P
Horti, A.G.; Zhang, Y.; Pavlova, O.A.; Chefer, S.I.; Vaupel, D.B.; Brown, L.L.; Hall, A.W.; Kimes, A.S.; Mukhin, A.G. 2003: PET radioligands with potential for imaging extrathalamic high affinity nicotinic acetylcholine receptor. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S64
Mishani, E.; Laki, D.; Wajnblum, D.; Chisin, R. 2002: PET radiopharmaceuticals dispensing unit. Journal of Nuclear Medicine 43(5 Suppl): 378P
Dougherty, D.D.; Bonab, A.A.; Alpert, N.M.; Rauch, S.L.; Fava, M.; Ottowitz, W.; Livni, E.; Fischman, A.J. 2000: PET receptor studies of major depression with anger attacks. Journal of Nuclear Medicine 41(5 Suppl): 199P
Mesotten, L.V.; Maes, A.; Herregods, M.C.; Desmet, W.; Nuyts, J.; Van, D.W.rf, F.; Mortelmans, L.A. 2000: PET reduced glucose uptake relative to perfusion pattern early after acute myocardial infarction treated with thrombolytic therapy. Circulation 102(18): 2; 770
Macmanus, M.P.; Hicks, R.J.; Salminen, E.; Hogg, A.; Matthews, J.; Wirth, A.; Rischin, D.; Ball, D.L. 2001: PET response is the most powerful predictor of survival after radical radiotherapy/chemoradiotherapy for unresectable non-small cell lung cancer. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 89
Esik, O.; Bodrogi, I.; Csere, T.; Safrany, G.; Vonoczky, K.; Tron, L. 2001: PET reveals increased metabolic activity of the spinal cord after partial recovery from radiation myelopathy. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 236-237
Mcdougall, I.R.; Segall, G.A. 2000: PET scan in patients with differentiated thyroid cancer who have disparate results from 131I scan and thyroglobulin. Journal of Nuclear Medicine 41(5 Suppl): 306P
Le, J.; Salmon, E.; Iacono, R.; Mohamed, A.; Keator, D.; Lee, A.; Wu, J. 1999: PET scan studies of Parkinsons disease in the on and off state. Society for Neuroscience Abstracts 25(1-2): 329
Mac Manus, M.P.; Salminen, E.; Millward, M.; Wirth, A.; Ball, D.L.; Kalff, V.; Khaw, P.; Mckenzie, A.; Hicks, R.J. 1999: PET scanning in 100 radical radiation therapy candidates with non-small cell lung cancer High impact on staging and management and delineation of a subgroup with poor survival. International Journal of Radiation Oncology Biology Physics 45(3 Suppl): 153-154
Gibis, B.R. 2002: PET scanning in oncology The HTA perspective. International Journal of Cancer Suppl (13): 69
Ho, A.; Chugani, H.T.; Juhasz, C.; Behen, M.E. 2003: PET scanning of tryptophan metabolism in Tourette Syndrome. Neurology 60(5 Suppl 1): A211
Chugani, H.T. 1999: PET scanning studies of human brain development and plasticity. Developmental Neuropsychology 16(3): 379-381
Wasserstein, M.P.; Snyderman, S.E.; Sansaricq, C.; Buchsbaum, M.S. 2001: PET scans abnormalities in adults with early-treated PKU. American Journal of Human Genetics 69(4 Suppl): 474
Derdeyn, C.P.; Gage, B.F.; Grubb, R.L.; Powers, W.J. 1999: PET screening prior to EC/IC bypass for symptomatic carotid occlusion A costeffectiveness analysis. Stroke 30(1): 240
Banzett, R.B.; Mulnier, H.E.; Murphy, K.; Rosen, S.D.; Wise, R.; Adams, L. 2000: PET shows anterior insular cortex activated with air hunger in healthy humans. FASEB Journal 14(4): A646
Adams, L.; Mulnier, H.E.; Murphy, K.; Rosen, S.D.; Wise, R.; Banzett, R.B. 2000: PET shows posterior insula cortex activated with increased tidal volume in healthy humans. FASEB Journal 14(4): A646
Tuominen, S.; Juvonen, V.; Poyhonen, M.; Tuisku, S.; Viitanen, M.; Kalimo, H.; Rinne, J.O. 2002: PET studies in Finnish CADASIL patients. Journal of the Neurological Sciences (203-204): 337
Dejesus, O.T.; Brown, W.D.; Shelton, S.E.; Roberts, A.D.; Nickles, R.J.; Holden, J.E. 1999: PET studies in rhesus monkeys using 6- -fluoro-meta-tyrosine, an aromatic L-amino acid decarboxylase tracer. Journal of Labelled Compounds and Radiopharmaceuticals 42(Suppl 1): S392-S394
Dejesus, O.T.; Endres, C.J.; Shelton, S.E.; Uno, H.; Nickles, R.J.; Holden, J.E. 1999: PET studies of 6-FMT and 6-FDOPA uptake in dopamine nerve terminals of rhesus macaques Age effects. Journal of Nuclear Medicine 40(5 Suppl): 264P
Dougherty, D.D.; Deckersbach, T.; Rauch, S.L.; Fava, M.; Fischman, A.J. 2003: PET studies of anger attacks in depressed patients with and without Anger attacks. Journal of Nuclear Medicine 44(5 Suppl): 248P
Parsey, R.V.; Hwang, D.R.; Simpson, N.; Guo, N.N.; Mawlawi, O.; Kegeles, L.S.; Bergert, B.; Montoya, J.; Popilskis, S.; Mann, J.J.; Laruelle, M. 1999: PET studies of competition between Carbonyl-WAY 100635 and endogenous serotonin. Journal of Nuclear Medicine 40(5 Suppl): 29P
Ding, Y.S.; Mueller, M.; Schwaegler, M.; Alexoff, D.; Roesch, F.; Fowler, J.S.; Volkow, N.D. 2003: PET studies of ephedrine and pseudoephedrine. Journal of Nuclear Medicine 44(5 Suppl): 219P
Van Waarde, A.; Elsinga, P.H.; Doze, P.; Jager, P.L.; Slart, R.H.; Frijlink, H.W.; Vaalburg, W. 2002: PET studies of human airways using inhaled 11C CGP 12388. Journal of Nuclear Medicine 43(5 Suppl): 350P
Mccann, U.D.; Wong, D.F.; Yuan, J.; Yokoi, F.; Dannals, R.F.; Ricaurte, G.A. 1999: PET studies of methamphetamine-induced dopamine neurotoxicity in the primate using WIN 35,428 and DTBZ. Society for Neuroscience Abstracts 25(1-2): 1823
Eberling, J.L.; Pivirotto, P.; Bringas, J.; Jagust, W.J.; Bankiewicz, K.S. 1999: PET studies of parkinsonian features and the nigrostriatal dopamine pathway in MPTP-lesioned monkeys. Society for Neuroscience Abstracts 25(1-2): 1343
Logan, J.; Fowler, J.S.; Ding, Y.S.; Franceschi, D.; Wang, G.J.; Volkow, N.D.; Pappas, N.; Schlyer, D.; Kaznatcheev, E.; Ferrieri, R.; Shea, C.; Macgregor, R.; Garza, V. 2001: PET studies of peripheral monoamine oxidase a. Journal of Nuclear Medicine 42(5 Suppl): 212P
Gulyas, B.Z.; Halldin, C.; Sandell, J.; Sovago, J.; Cselenyi, Z.S.; Karlsson, P.; Vas, A.; Karpati, E.; Kiss, B.; Farde, L. 2001: PET studies on brain uptake and distribution of orally and intravenously administered 11Cvinpocetine A novel principle of radiotracer administration. Journal of Nuclear Medicine 42(5 Suppl): 212P-213P
Gulyas, B.; Halldin, C.; Langer, O.; Karlsson, P.; Sovago, J.; Cselenyi, Z.S.; Laszlovszky, I.; Kiss, B.; Farde, L. 2001: PET studies on brain uptake and distribution of the dopamine D3 radioligand 11CRGH-1756. Journal of Nuclear Medicine 42(5 Suppl): 211P
Brooks, D.J. 2003: PET studies on the function of dopamine in health and Parkinson's disease. Annals of the new York Academy of Sciences 991: 22-35
Rosa, P.; Andermann, F.; Natsume, J.; Lisbona, R.; Okasawa, H.; Dubeau, F.; Kumakura, Y.; Diksic, M. 2000: PET studies using aminoacids tracers Multimodal analysis. Epilepsia 41(Suppl 7): 58-59
Anderson, K.E.; Zubin, N.; Dimauro, A.; Park, A.; Van Heertum, R.; Stern, Y. 1999: PET study of change in neural networks in Alzheimers patients at one year follow-up on a word recognition task. Neurology 52(6 Suppl 2): A369-A370
D.V.ies, E.F.J.; Hospers, G.A.P.; Van Waarde, A.; Harmsen, M.C.; Vaalburg, W. 1999: PET tracers for herpes simplex virus thymidine kinase gene transfer and cytomegalovirus infections. Journal of Nuclear Medicine 40(5 Suppl): 198P
Mathis, C.A.; Lopresti, B.J.; Davis, J.G.; Ruszkiewicz, J.; Capuano, S.V.; Murphey Corb, M.; Myers, R.; Wiley, C.W. 2001: PET visualization of peripheral benzodiazepine receptor expression using 11CPK-11195 in macaque monkeys with SIV. Journal of Nuclear Medicine 42(5 Suppl): 212P
Palmedo, H.; Schaible, R.; Textor, J.; Ko, Y.; Grohe, C.; Von Mallek, D.; Ezziddin, S.; Reinhardt, M.J.; Biersack, H.J. 2002: PET with 18F fluoride compared to bone scintigraphy in the diagnosis of bone metastases Results of a prospective study. Journal of Nuclear Medicine 43(5 Suppl): 285P
Ribeiro, M.J.; Norol, F.; Merlet, P.; Deverre, J.R.; Dolle, F.; Syrota, A. 2003: PET with C-11 acetate to monitor therapeutic use of mobilized stem cells for myocardial infarct repair in baboons. Journal of Nuclear Medicine 44(5 Suppl): 192P-193P
Dimitrakopoulou Strauss, A.; Schwarzbach, M.; Willeke, F.; Strauss, L.G. 2000: PET with FDG in soft tissue sarcomas. Journal of Nuclear Medicine 41(5 Suppl): 303P
Eckerle, S.; Reincke, B.; Kirrstetter, M.; Reinhold Keller, E.; Gross, W.L.; Richter, E.; Baehre, M. 2003: PET with a coincidence gamma camera in diagnosing giant-cell vasculitis. Journal of Nuclear Medicine 44(5 Suppl): 199P
Lundin, N.; Malmstrom, P.U.; Haggman, M.; Sandblom, G.; Sorensen, J. 2004: PET with acetate for localization of tumour in patients with PSA relapse after radical prostatectomy. European Urology Suppls 3(2): 174
Pio, B.S.; Park, C.K.; Satyamurthy, N.; Czernin, J.; Phelps, M.E.; Silverman, D.H. 2003: PET with fluoro-L-thymidine allows early prediction of breast cancer response to chemotherapy. Journal of Nuclear Medicine 44(5 Suppl): 76P-77P
Segars, W.P.; Tsui, B.M.; Da Silvia, A.J.; Shao, L. 2002: PET-CT image fusion using the new 4D NURBS-based CArdiac-Torso phantom. Journal of Nuclear Medicine 43(5 Suppl): 13P
Wang, Y.; Yu, J.; Liu, J.; Tong, Z.; Sun, X.; Yang, G. 2003: PET-CT in the diagnosis of both primary breast cancer and axillary lymph node metastasis Initial experience. International Journal of Radiation Oncology Biology Physics 57(2 Suppl): S362-S363
Jacobs, A.; Voges, J.; Reszka, R.; Lercher, M.; Gossmann, A.; Kracht, L.; Kaestle, C.; Weisner, N.; Wagner, R.; Wienhard, K.; Sturm, V.; Heiss, W.D. 2001: PET-based imaging of HSV-1-TK gene expression in a phase I/II clinical glioma gene therapy trial. Journal of Nuclear Medicine 42(5 Suppl): 64P
Jacobs, A.; Tjuvajev, J.; Dubrovin, M.; Akhurst, T.; Balatoni, J.; Beattie, B.; Finn, R.; Larson, S.; Herrlinger, U.; Pechan, P.; Chiocca, E.A.; Breakefield, X.O.; Blasberg, R.G. 2001: PET-based imaging of gene expression mediated by oncolytic HSV-1 mutant vectors in vivo. Journal of Nuclear Medicine 42(5 Suppl): 64P
Zanzonico, P.; Finn, R.; Pentlow, K.S.; Erdi, Y.; Beattie, B.; Humm, J.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; Mccarthy, T.; Welch, M.; Larson, S.M. 2002: PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone , a new radiotracer for imaging prostate cancer. Journal of Nuclear Medicine 43(5 Suppl): 87P
Wuest, F.; Reul, J.M.H.M.; Rein, T.; Abel, A.; Stoecklin, G. 2001: PET-corticosteroids as potential ligands for mapping brain glucocorticoid receptors. Journal of Labelled Compounds and Radiopharmaceuticals 44(Suppl 1): S12-S14
Henze, M.; Bischoff, H.; Schuhmacher, J.; Maecke, H.R.; Eisenhut, M.; Haberkorn, U. 2002: PET-imaging of somatostatin receptors in small cell lung cancer with 68Ga-DOTA0-D Phe1-Tyr3-Octreotide. Journal of Nuclear Medicine 43(5 Suppl): 114P
Schindler, T.H.; Prior, J.O.; Inubishi, M.; Facta, A.; Nitzsche, E.U.; Schelbert, H.R. 2003: PET-measured responses in myocardial blood flow to cold pressor testing correlate with indices of coronary vasomotion on quantitative angiography. Journal of Nuclear Medicine 44(5 Suppl): 89P
Ducreux, M.; Taieb, J.; Boige, V.; Lasser, P.; Elias, D.; Lumbroso, J. 2003: PET-scan and digestive oncology. Gastroenterologie Clinique et Biologique 27(Suppl 5): B71-B78
Klinge, P.; Berding, G.; Brinker, T.; Schuhmann, M.; Knapp, W.H.; Samii, M. 2002: PET-studies in idiopathic chronic hydrocephalus before and after shunt-treatment The role of risk factors for cerebrovascular disease on cerebral hemodynamics. Czosnyka, M , Reprint Author, Pickard, J D, Kirkpatrick, P J, Smielewski, P, Hutchinson, P Intercranial pressure and brain biochemical monitoring: 43-45
Nakamoto, Y.; Osman, M.; Cohade, C.; Marshall, L.T.; Links, J.M.; Wahl, R.L. 2002: PET/CT Comparison of quantitative tracer uptake between germanium and CT transmission attenuation correction maps. Journal of Nuclear Medicine 43(5 Suppl): 13P
Mehta, L.; Nelson, A.D.; Devlin, A.L.; Kraly, B.M.; Faulhaber, P.F.; Sodee, D.B.; Odonnell, J.K.; Greskovich, J.P. 2003: PET/CT fusion consistency utilizing an immobilization device for purposes of patient positioning. Journal of Nuclear Medicine 44(5 Suppl): 268P
Czernin, J.; Schelbert, H. 2004: PET/CT imaging Facts, opinions, hopes, and questions. Journal of Nuclear Medicine 45(1 Suppl): 1S-3S
Makhija, S.; Howden, N.; Comerci, J.; Kelley, J.; Kunschner, A.; Meltzer, C.; Sumkin, J.; Edwards, R. 2001: PET/CT imaging for the detection of recurrent ovarian and fallopian tube cancer A retrospective review. Proceedings of the American Association for Cancer Research 42: 51
Fukui, M.B.; Blodgett, T.M.; Meltzer, C.C. 2003: PET/CT imaging in recurrent head and neck cancer. Seminars in Ultrasound Ct and Mr 24(3): 157-163
Meltzer, C.C.; Makhija, S.; Howden, N.; Sumkin, J.; Edwards, R.; Comerci, J.; Mccook, B.; Townsend, D.W. 2001: PET/CT imaging in recurrent ovarian and fallopian tube carcinoma. Journal of Nuclear Medicine 42(5 Suppl): 284P
Blodgett, T.M.; Meltzer, C.C.; Townsend, D.W.; Yap, J.T.; Mccook, B.M.; Heron, D.E.; Gerszten, K.; Sit, A.; Edwards, R.; Comerci, J.; Gallion, H. 2002: PET/CT in re-staging patients with ovarian carcinoma. Journal of Nuclear Medicine 43(5 Suppl): 310P
Blodgett, T.M.; Meltzer, C.C.; Townsend, D.W.; Yap, J.T.; Mccook, B.M.; Heron, D.E.; Gerszten, K.; Sit, A.; Edwards, R.; Comerci, J.; Gallion, H. 2002: PET/CT in staging and re-staging patients with cervical carcinoma. Journal of Nuclear Medicine 43(5 Suppl): 310P
Townsend, D.W.; Beyer, T.; Blodgett, T.M. 2003: PET/CT scanners: a hardware approach to image fusion. Seminars in Nuclear Medicine 33(3): 193-204
Bar Shalom, R.; Keidar, Z.; Engel, A.; Nitecki, S.; Hoffman, A.; Israel, O. 2003: PET/CT using FDG for the evaluation of suspected infected vascular graft. Journal of Nuclear Medicine 44(5 Suppl): 339P
Ruiz Hernandez, G.; Burzaco, J.A.; Montz, R.; Erustes, M.; Aramburo, P.; Alvarez Linera, J.; Lapena, L.; Carreras Delgado, J.L. 2002: PET/RMN in patients with hydrocephalia and brain metastases treated with radiosurgery. Oncologia 25(6): 54-58
Michelakakis, H.; Zafeiriou, D.; Moraitou, M.; Goutjes, J.; Vreken, P.; Wanders, R. 2001: PEX1 deficiency misdiagnosed as Lebers congenital amaurosis. Journal of Inherited Metabolic Disease 24(Suppl 1): 92
Huber, Y.; Grossschopf, K.; Riepl, M.; Hartig, A. 2003: PEX15p A player in de novo peroxisome biogenesis?. Yeast 20(Suppl 1): S34
Weller, S.; Gould, S.J.; Moser, H.W.; Valle, D. 2003: PEX26 mutations and cellular phenotype of patients with complementation group 8 peroxisome biogenesis disorder. American Journal of Human Genetics 73(5): 464
Braverman, N.E.; Obie, C.; Lin, P.; Valle, D.; Moser, A.B.; Moser, H.W.; Steinberg, S.J. 2001: PEX6 mutation identification in 20 patients with peroxisome biogenesis disorders. American Journal of Human Genetics 69(4 Suppl): 491
Jimenez Medina, E.; Martinez Llamas, M.; Paco, L.; Algarra, I.; Garcia Lora, A.M.; Garrido, F. 2004: PF2 A new immunomodulator acting on lymphocyte cell proliferation. Genes and Immunity 5(Suppl 1): S70
Arepally, G.; Homi, H.M.; Mccracken, E.M.; Goss, T.M.; Grocott, H.P. 2003: PF4/heparin autoantibodies in a rat model of cardiopulmonary bypass. Blood 102(11): 535a
Lee, J.; Wood, W.I. 1999: PF4A receptor. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)
Schulz Stuebner, S.; Rossaint, R. 2001: PFA 100-bleeding time as a marker of ASA-induced platelet dysfunction A reliable method before spinal or epidural anesthesia?. Regional Anesthesia and Pain Medicine 26(2 Suppl): 45
Lopez Pastor, A.; Carcamo, C.; Sobrino, N.; Galeote, G.; Fernandez Chacon, J.L. 2000: PFA 100TM system A rapid assay to assess the variable platelet inhibition response with abciximab in patients undergoing percutaneous coronary intervention. Haemostasis 30(Suppl 1): 92-93
Gasser, K.; Lammle, B.; Sulzer, I.; Wuillemin, W.A. 1999: PFA-100 Evaluation of a new method and influence of Acetylsalicylic Acid. Annals of Hematology 78(Suppl 1): A74
Crowe, B.H.; Abass, S.; Meaney, B.; Horgan, P.; Cahill, M.R. 1999: PFA-100 Platelet function in stable angina patients - Is there a subgroup of aspirin non responders?. British Journal of Haematology 105(Suppl 1): 48
Kugelmass, A.D.; Comp, P.C. 1999: PFA-100 platelet function assay detects platelet inhibition with tirofiban. Journal of the American College of Cardiology 33(2 Suppl A): 330A
Gorog, D.A.; Davies, G.J. 2000: PFA100 demonstrates accelerated haemostasis with raised von Willebrand factor antigen level. Journal of Submicroscopic Cytology and Pathology 32(3): 411
Patton, Lucinda; El Dahr, Jane M. 2002: PFAPA syndrome in two patients with immunodeficiency. Journal of Allergy and Clinical Immunology 109(1 Suppl): S194
Peres, N.A.R.; Kim, S.; Beck, H.W.; Souza, N.L.; Timmer, L.W. 2002: PFD-FAD, an expert system for timing fungicide applications for control of postbloom fruit drop. Phytopathology 92(6 Suppl): S64-S65
Galluzzi, G.; Colantoni, L.; Rossi, M.; Merico, B.; Mangiola, F.; Tonali, P.; Ricci, E.; Felicetti, L. 2001: PFGE analysis of 4q35 rearrangements in Italian families with facioscapulohumeral muscular dystrophy ; implications for the molecular mechanism of the disease. European Journal of Human Genetics 9(Suppl 1): P1506
Felicetti, L.; Galluzzi, G.; Colantoni, L.; Rossi, M.; Merico, B.; Mangiola, F.; Tonali, P.; Ricci, E. 2001: PFGE analysis of 4qter-10qter interchromosomal exchanges in Italian families with facioscapulohumeral muscular dystrophy. American Journal of Human Genetics 69(4 Suppl): 651
Galluzzi, G.; Colantoni, L.; Bonifazi, E.; Deidda, G.; Cacurri, S.; Mangiola, F.; Ricci, E.; Felicetti, L. 1999: PFGE analysis of 4qter-10qter subtelomeric exchanges in normal and FSHD affected individuals Implications for the molecular diagnosis and genetic counseling of the disease. American Journal of Human Genetics 65(4): A297
Arellano, K.H.; Cravioto, A.; Lopez Vidal, Y. 2000: PFGE patterns of enterotoxigenic E coli bearing CFA/I family fimbriae. Abstracts of the General Meeting of the American Society for Microbiology 100: 147
Massa, L.; Baltrusch, S.; Lenzen, S.; Tiedge, M. 2003: PFK-2/FBPase-2 is an activator of glucokinase activity in insulin-producing cells. Diabetologia 46(Suppl 2): A156
Sievert, H.; Trepels, T.; Zadan, E.; Horvath, K.; Krumsdorf, U.; Fach, A.; Schrader, R.; Scherer, D.; Spies, H.; Lissmann Jensen, H.; Nowak, B.; Beykirch, K.F.; Theis, R.; Zeplin, H. 2001: PFO catheter closure for prevention of recurrent embolic stroke and TIA in 400 patients Acute results and follow-up. Circulation 104(17): 2; 670
Longmire, J.L.; Brown, N.C. 2003: PFOS-LA: a modified vector for production of random shear fosmid libraries. Biotechniques 35(1): 50
Borkowski, J.A.; Smith, C.P.; Huang, X. 2000: PFP A flexible integrated filtering and masking tool. International Genome Sequencing and Analysis Conference 12: 51
Canio, W.C.; Sinha, N.R. 2000: PFP-LeT6 gene fusion product moves in the phloem. Plant Biology (Rockville) : 49
Buckheit, R.W.J.; Parsley, T.B.; Brenner, T.L. 2004: PG 301029 inhibits the HCV surrogate BVDV through a novel late stage mechanism of action. Antiviral Research 62(2): A86
Yousef, Eman A.; Al Jamali, Abbas F.; Ereifej, Khalil I. 2000: PG macerating activity of Long Shelf Life and regular tomatoes. Plant Biology (Rockville) : 78
Sabbah, H.N.; Morita, H.; Suzuki, G.; Sharov, V.G.; Todor, A.; O'neill, T.P. 2004: PG-530742, a novel matrix metalloproteinase inhibitor, improves left ventricular function and attenuates remodeling in dogs with chronic heart failure. Journal of the American College of Cardiology 43(5 Suppl A): 22A
Li, K.K.; Fidler, J.M. 2001: PG490-88 exerts potent anticancer activity alone and in combination therapy in a nude mouse xenograft model. Proceedings of the American Association for Cancer Research 42: 73
Spiegelman, B.M.; Puigserver, P.; Wu, Z. 2000: PGC-1, a novel brown fat PPARgamma coactivator. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)
Oberkofler, H.; Krempler, F.; Patsch, W. 2004: PGC-1alpha A multifunctional transcriptional coactivator involved in human metabolic disorders. Current Genomics 5(5): 443-451
Del Rincon, J.P.; Itoh, E.; Kim, D.S.; IIda, K.; Thorner, M.O. 2004: PGC-1alpha mRNA levels are increased in skeletal muscle of lit/lit GH deficient mice between 1200 and 1400 H and are further increased by GH administration. Growth Hormone and IGF Research 14(2): 134
Karen, S. 2001: PGD diagnosis of monogenic disorders at the VUB, Brussels. Fetal Diagnosis and Therapy 16(6): 454-455
Feliciani, E.; Ferraretti, A.P.; Gerin, F.; Fortini, D.; Magli, M.C.; Gianaroli, L. 2000: PGD for aneuploidy as a tool to avoid the need of transferring more than two embryos. Human Reproduction 15(Abstract Book 1): 182-183
Kearns, W.G.; Graham, J.; Han, T.; Carter, J.; Davis, A.; Richter, K.S.; Widra, E.; Levy, M.J. 2003: PGD for aneuploidy on 513 embryos from 56 initiated cycles using laser assisted embryo biopsy and FISH significantly increases implantation rates, reduces miscarriages, and decreases multiple births. American Journal of Human Genetics 73(5): 592
Deugarte, C.M.; Li, M.; Hill, D.; Danzer, H.; Surrey, M. 2004: PGD results in embryos with odd versus even cell number on day 3 after retrieval. Fertility and Sterility 81(Suppl 3): S22
Hirai, H.; Tanaka, K.; Takano, S.; Nakamura, M.; Nagata, K. 2003: PGD2 in allergy, PGD2 has dual receptor systems. Journal of Pharmacological Sciences 91(Suppl I): 16P
Jabbour, H.N.; Milne, S.A.; Boddy, S.C. 2000: PGE induces endothelial cell proliferation via a PKA-dependent pathway. Journal of Endocrinology 167(Suppl): P55
Horiuchi, T.; Sakamoto, H.; Suematsu, A.; Yoshida, T.; Yamamoto, S.; Oda, H.; Koshihara, Y. 2000: PGE is a relevant mediator in the expression of PTHrP induced by interleukin-1 in the synovial fibroblasts of rheumatoid arthritis. Journal of Bone and Mineral Research 15(Suppl 1): S569
Ramaswamy, K.; Kumar, P.; He, Y.X. 2000: PGE/2-dependent, IL-10 mediated host immunoregulation by skin-stage schistosomula of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 155
Yoshikawa, H.; Sasaki, H.; Seki, J. 1999: PGE1 -containing-freeze dried preparation and process for the production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1228(1)
Mork, C.; Kvernebo, K. 2000: PGE1 analogue treatment reduces symptoms in erythromelalgia. Journal of Vascular Research 37(Suppl 1): 17
Iversen, V.V.; Reed, R.K. 2002: PGE1 induced transcapillary transport of 51Cr-EDTA in rat skin measured by microdialysis. Acta Physiologica Scandinavica 176(4): 269-274
Seidel, C.L.; Helgason, T.; Ma, K.; Lloyd, E.; Allen, J.; Burns, A.R. 1999: PGE1 inhibition of vascular smooth muscle cell migration includes elevation in cAMP and cytoskeletal reorganization. FASEB Journal 13(5 Part 2): A1008
Muntane, Jordi; Siendones, Emilio; Elsaid, Amira Mohamed Kamal; Montero, Jose Luis; De La Mata, Manuel; Munoz, Eduardo; Fernandez Checa, Jose Carlos; Mino, Gonzalo 2000: PGE1 protection against D-galactosamine-induced apoptosis is through NF-kB activation. Hepatology 32(4 Pt 2): 204A
Siendones, E.; Muntane, J.; Quintero, A.; Montero, J.L.; Fernandez Checa, J.C.; De La Mata, M.; Mino, G. 2000: PGE1 reduced caspase-3 and -6 activation induced by D-galactosamine in primary culture of rat hepatocytes, role of oxidative stress. Journal of Hepatology 32(Suppl 2): 81
Geisel, J.; Borsick, M.; Taub, M.L. 2003: PGE1 stimulated transcription of the Na,K-ATPase in MDCK cells PKC alpha and delta involvement. Proceedings of the American Association for Cancer Research 44: 997
Vassiliou, E.K.; Sharma, V.; Jing, H.; Ganea, D. 2004: PGE2 Protects Dendritic Cells from Stress Induced Apoptosis. FASEB Journal 18(4-5): Abstract 774
Nagamatsu, T.; Nagao, T.; Mmaruyama, T.; Suzuki, Y. 1999: PGE2 accelerates disposal of aggregated protein via prostaglandin E2 receptor subtype EP4 in glomeruli. Prostaglandins and Other Lipid Mediators 59(1-6): 214
Kopp, U.C.; Cicha, M.Z.; Smith, L.A.; Nuesing, R.M.; Hokfelt, T. 2004: PGE2 activates renal pelvic sensory nerves by stimulating EP4 receptors. FASEB Journal 18(4-5): Abstract 445
Sauvant, C.; Holzinger, H.; Gekle, M. 2002: PGE2 acutely stimulates basolateral uptake of organic anions by receptor mediated activation of PKA in proximal tubular OK cells. Kidney and Blood Pressure Research 25(3): 139-140
Akiba, Y.; Guth, P.H.; Engel, E.; Kaunitz, J.D. 2000: PGE2 and acid induce rat duodenal epithelial alkalinization and HCO3- secretion via activation of the Na+HCO3- cotransporter and CFTR. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A861